| |
British Columbia
(State or other jurisdiction of
incorporation or organization) |
| |
3812
(Primary Standard Industrial
Classification Code Number) |
| |
83-0954794
(I.R.S. Employer
Identification No.) |
|
| |
Copies to:
|
| ||||||
| |
Stephen Older
Barlow Mann Carly Ginley McGuireWoods LLP 1251 6th Avenue, 20th Floor New York, New York 10020 (212) 548-2100 |
| |
Desmond Balakrishnan
McMillan LLP Royal Centre 1055 W Georgia St #1500 Vancouver, BC V6E 4N7, Canada (604) 689-9111 |
| |
Steven Skolnick
Tracy Buffer Lowenstein Sandler LLP 1251 Avenue of the Americas New York, New York 10020 (646) 414-6947 |
|
| | | | | | 4 | | | |
| | | | | | 6 | | | |
| | | | | | 7 | | | |
| | | | | | 13 | | | |
| | | | | | 15 | | | |
| | | | | | 18 | | | |
| | | | | | 54 | | | |
| | | | | | 55 | | | |
| | | | | | 56 | | | |
| | | | | | 58 | | | |
| | | | | | 59 | | | |
| | | | | | 61 | | | |
| | | | | | 82 | | | |
| | | | | | 105 | | | |
| | | | | | 113 | | | |
| | | | | | 121 | | | |
| | | | | | 122 | | | |
| | | | | | 123 | | | |
| | | | | | 125 | | | |
| | | | | | 132 | | | |
| | | | | | 134 | | | |
| | | | | | 140 | | | |
| | | | | | 142 | | | |
| | | | | | 150 | | | |
| | | | | | 152 | | | |
| | | | | | 152 | | | |
| | | | | | 152 | | | |
| | | | | | 152 | | | |
| | | | | | F-1 | | |
| | | |
Nine months ended
September 30, 2025 (C$) |
| |
Year ended
December 31, 2024 (C$) |
| |
Year ended
December 31, 2023 (C$) |
| |||||||||
|
As of end of period
|
| | | | 1.3921 | | | | | | 1.4389 | | | | | | 1.3226 | | |
|
Low for the period
|
| | | | 1.3575 | | | | | | 1.3316 | | | | | | 1.3128 | | |
|
High for the period
|
| | | | 1.3941 | | | | | | 1.4416 | | | | | | 1.3875 | | |
|
Average rate for the period
|
| | | | 1.3773 | | | | | | 1.3698 | | | | | | 1.3497 | | |
| | Issuer | | | Liberty Defense Holdings, Ltd. | |
| |
Common Shares offered by us
|
| | Up to 3,888,889 Common Shares. | |
| |
Pre-Funded Warrants offered by us
|
| | We are also offering to certain purchasers whose purchase of Common Shares in this offering would otherwise result in the purchaser, together with its affiliates and certain related parties, beneficially owning more than 9.99% of our outstanding Common Shares immediately following the consummation of this offering, up to 3,888,889 Pre-Funded Warrants, in lieu of Common Shares. The purchase price of each Pre-Funded Warrant will be equal to the price at which one Common Share is sold to the public in this offering, minus US$0.0001, and the initial exercise price of each Pre-Funded Warrant will be US$0.0001 per Common Share. The Pre-Funded Warrants will be immediately exercisable and may be exercised at any time until all of the Pre-Funded Warrants are exercised in full. For each Pre-Funded Warrant we sell, the number of Common Shares we are offering will be decreased on a one-for-one basis. We are registering the Common Shares issuable from time to time upon exercise of the Pre-Funded Warrants. See “Description of Securities to be Registered — Pre-Funded Warrants. | |
| |
Assumed initial public offering price
|
| | US$4.50 per Common Share, the midpoint of the range set forth on the cover page of this prospectus | |
| |
Over-Allotment Option
|
| | We have granted a 30-day option to the underwriter, exercisable one or more times in whole or in part, to purchase up to an additional 583,333 Common Shares, representing 15% of the Common Shares and Pre-Funded Warrants sold in this offering, at the initial public offering price, less the underwriting discounts payable by us, solely to cover over-allotments, if any (the “Over-Allotment Option”). | |
| |
Common Shares to be outstanding after this offering(1)
|
| | 5,873,192 Common Shares (or 6,456,525 Common Shares if the underwriter exercises the Over-Allotment Option in full), assuming no sale of Pre-Funded Warrants, which, if sold, would reduce the number of Common Shares that we are offering on a one-for-one basis. | |
| | Listing | | |
Our Common Shares are listed on the TSXV under the symbol “SCAN,” quoted on the OTCQB under the symbol of “LDDFF” and listed on the FSE under the symbol of “4XS.” We have applied to list our Common Shares on Nasdaq under the symbol “DETX.”
There is no established public trading market for the Pre-Funded Warrants, and we do not intend to list the Pre-Funded Warrants on any national securities exchange or trading system. Without a trading market, the liquidity of the Pre-Funded Warrants will be limited.
|
|
| |
Use of proceeds
|
| | We estimate that the net proceeds from this offering will be approximately US$14.7 million (or US$17.1 million if the underwriter exercises the Over-Allotment Option in full), after | |
| | | | | deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us, based on the assumed initial public offering price of US$4.50 per Common Share. | |
| | | | | We intend to use the net proceeds from this offering for working capital and other general corporate purposes, including commercialization of our HD-AIT Upgrade Kit, business development activities associated with the sale of HEXWAVE™ and recurring engineering and cost reduction efforts for next generation HEXWAVE™. In addition, we may be required to use a portion of the net proceeds from this offering to repay amounts owed under the Parabilis Credit Facilities and/or to Viken, which would reduce the funds available for working capital and other general corporate purposes. See “Risk Factors — Risks Relating to our Financial Condition — We have granted competing security interests in substantially all the assets of Liberty Defense Technologies, Inc., our wholly owned subsidiary, which could materially adversely affect us.” We have not allocated specific amounts of net proceeds for any of these purposes. See “Use of Proceeds” for additional information. | |
| | Lock-up | | | We and our directors and executive officers have agreed, subject to certain exceptions, not to sell or otherwise dispose of Common Shares or any securities convertible into or exchangeable for Common Shares for a period of one hundred eighty (180) days after the closing of this offering without the prior written consent of the underwriter. See “Underwriting” for additional information. | |
| |
Risk factors
|
| | Investing in our securities involves a high degree of risk. See “Risk Factors” for a discussion of factors you should carefully consider before investing in our securities. | |
| | | |
Year Ended December 31,
(Audited) |
| |||||||||
|
Consolidated Statements of Loss and Comprehensive Loss:
|
| |
2024
US$ |
| |
2023
US$ |
| ||||||
| Revenue | | | | | | | | | | | | | |
|
HEXWAVE™ revenue
|
| | | | 1,013,546 | | | | | | 120,000 | | |
|
Contract revenue
|
| | | | 1,425,000 | | | | | | 1,372,557 | | |
|
Total revenue
|
| | | | 2,438,546 | | | | | | 1,492,557 | | |
| Cost of revenue | | | | | | | | | | | | | |
|
HEXWAVE™ cost of revenue
|
| | | | 2,033,498 | | | | | | 1,546,040 | | |
|
Contract cost of revenue
|
| | | | 2,081,971 | | | | | | 1,163,211 | | |
|
Total cost of revenue
|
| | | | 4,115,469 | | | | | | 2,709,251 | | |
|
Gross loss
|
| | | | (1,676,923) | | | | | | (1,216,694) | | |
|
Engineering, Research and Development and General and Administrative Expenses
|
| | | | 5,756,941 | | | | | | 7,890,649 | | |
|
Other expenses (income)
|
| | | | 1,411,299 | | | | | | 261,700 | | |
|
Net loss
|
| | | | (8,845,163) | | | | | | (9,369,043) | | |
|
Other comprehensive loss
|
| | | | 192,175 | | | | | | 31,598 | | |
|
Total loss and comprehensive loss
|
| | | | (8,652,988) | | | | | | (9,337,445) | | |
|
Weighted average number of Common Shares outstanding – basic and diluted
|
| | | | 381,350 | | | | | | 284,812 | | |
|
Basic and diluted loss per share
|
| | | | (23.19) | | | | | | (32.90) | | |
| | | |
Nine Months Ended
September 30, (Unaudited) |
| |||||||||
|
Consolidated Statements of Loss and Comprehensive Loss:
|
| |
2025
US$ |
| |
2024
US$ |
| ||||||
| Revenue | | | | | | | | | | | | | |
|
HEXWAVE™ revenue
|
| | | | 909,407 | | | | | | 1,447,532 | | |
|
Contract revenue
|
| | | | 854,849 | | | | | | 1,250,000 | | |
|
Total revenue
|
| | | | 1,764,256 | | | | | | 2,697,532 | | |
| Cost of revenue | | | | | | | | | | | | | |
|
HEXWAVE™ cost of revenue
|
| | | | 2,112,884 | | | | | | 2,408,789 | | |
|
Contract cost of revenue
|
| | | | 1,493,636 | | | | | | 1,796,912 | | |
|
Total cost of revenue
|
| | | | 3,606,520 | | | | | | 4,205,701 | | |
|
Gross loss
|
| | | | (1,842,264) | | | | | | (1,508,169) | | |
|
Development and General and Administrative Expenses
|
| | | | 8,160,104 | | | | | | 4,343,864 | | |
|
Other expenses
|
| | | | 507,838 | | | | | | 577,694 | | |
| | | |
Nine Months Ended
September 30, (Unaudited) |
| |||||||||
|
Consolidated Statements of Loss and Comprehensive Loss:
|
| |
2025
US$ |
| |
2024
US$ |
| ||||||
|
Net loss
|
| | | | (10,510,206) | | | | | | (6,429,727) | | |
|
Other comprehensive loss
|
| | | | 112,660 | | | | | | 113,547 | | |
|
Total comprehensive loss
|
| | | | (10,397,546) | | | | | | (6,316,180) | | |
|
Weighted average number of Common Shares outstanding – basic and diluted
|
| | | | 1,234,756 | | | | | | 356,379 | | |
|
Basic and diluted loss per share
|
| | | | (8.51) | | | | | | (18.04) | | |
| | |||||||||||||
| | | |
Year Ended
December 31, (Audited) |
| |||||||||
|
Consolidated Statements of Cash Flows:
|
| |
2024
US$ |
| |
2023
US$ |
| ||||||
|
Cash used in operating activities
|
| | | | (6,469,264) | | | | | | (5,537,021) | | |
|
Cash used in investing activities
|
| | | | (121,217) | | | | | | (221,095) | | |
|
Cash provided by financing activities
|
| | | | 7,781,755 | | | | | | 5,069,546 | | |
|
Effect of foreign exchange rate changes on cash
|
| | | | (39,008) | | | | | | 12,060 | | |
| | | |
Nine Months
Ended September 30, (Unaudited) |
| |||||||||
|
Consolidated Statements of Cash Flows:
|
| |
2025
US$ |
| |
2024
US$ |
| ||||||
|
Cash used in operating activities
|
| | | | (8,379,896) | | | | | | (3,072,818) | | |
|
Cash used in investing activities
|
| | | | (176,498) | | | | | | (125,206) | | |
|
Cash provided by financing activities
|
| | | | 7,931,412 | | | | | | 3,474,239 | | |
|
Effect of foreign exchange rate changes on cash
|
| | | | 112,660 | | | | | | 113,338 | | |
| | | |
As of September 30, 2025
(Unaudited) |
| |||||||||||||||
|
Consolidated Statements of Financial Position:
|
| |
Actual
US$ |
| |
As adjusted(1)
US$ |
| |
As further
adjusted(2) US$ |
| |||||||||
|
Cash
|
| | | | 640,907 | | | | | | 2,543,900 | | | | | | 17,251,764 | | |
|
Total assets
|
| | | | 6,754,164 | | | | | | 8,657,157 | | | | | | 23,365,021 | | |
|
Total liabilities
|
| | | | 8,584,552 | | | | | | 8,584,552 | | | | | | 8,584,552 | | |
|
Deficit
|
| | | | (56,835,418) | | | | | | (56,835,418) | | | | | | (56,835,418) | | |
|
Total shareholders’ (deficiency) equity
|
| | | | (1,830,388) | | | | | | 72,605 | | | | | | 14,780,469 | | |
| | | |
As of September 30, 2025
|
| | | | |||||||||||||||
| | | |
Actual
|
| |
As adjusted
|
| |
As further
adjusted(1) |
| | |||||||||||
| | | |
(unaudited)
|
| |
(unaudited)
|
| |
(unaudited)
|
| | |||||||||||
|
Cash
|
| | | US$ | 640,907 | | | | | US$ | 2,543,900 | | | | | US$ | 17,251,764 | | | | ||
|
Debt:
|
| | | | | | | | | | | | | | | | | | | | ||
|
Parabilis term loan
|
| | | | 2,642,526 | | | | | | 2,642,526 | | | | | | 2,642,526 | | | | ||
|
Factoring liability
|
| | | | 797,975 | | | | | | 797,975 | | | | | | 797,975 | | | | ||
|
Lease liabilities – current portion
|
| | | | 236,709 | | | | | | 236,709 | | | | | | 236,709 | | | | ||
|
Lease liabilities – non-current portion
|
| | | | 345,534 | | | | | | 345,534 | | | | | | 345,534 | | | | ||
|
Total Debt
|
| | | | 4,022,744 | | | | | | 4,022,744 | | | | | | 4,022,744 | | | | ||
| Shareholders’ deficiency: | | | | | | | | | | | | | | | | | | | | | ||
|
Share capital
|
| | | | 48,894,901 | | | | | | 50,797,893 | | | | | | 65,505,758 | | | | ||
|
Equity reserves
|
| | | | 6,026,365 | | | | | | 6,026,365 | | | | | | 6,026,365 | | | | ||
|
Accumulated other comprehensive loss
|
| | | | 83,764 | | | | | | 83,764 | | | | | | 83,764 | | | | ||
|
Deficit
|
| | | | (56,835,418) | | | | | | (56,835,418) | | | | | | (56,835,418) | | | | ||
|
Total shareholders’ (deficiency) equity
|
| | | US$ | (1,830,388) | | | | | US$ | 72,605 | | | | | US$ | 14,780,469 | | | | ||
|
Total capitalization
|
| | US$ 2,192,356 | | | | US$ | 4,095,349 | | | | | US$ | 18,803,213 | | | | |||||
| |
Assumed initial public offering price per Common Share
|
| | | | | | | | | US$ | 4.50 | | |
| |
Net tangible book value (deficit) per Common Share as of September 30,
2025 |
| | | US$ | (2.48) | | | | | | | | |
| |
As adjusted net tangible book value (deficit) per Common Share as of September 30, 2025
|
| | | US$ | (1.11) | | | | |||||
| |
Increase in as adjusted net tangible book value per Common Share attributable to new investors
|
| |
US$3.31
|
| | | | | | | |||
| |
As further adjusted net tangible book value per Common Share after this offering
|
| | | | | | | | | US$ | 2.20 | | |
| |
Dilution per Common Share to new investors participating in this offering
|
| | | | | | | | | US$ | 2.30 | | |
| | | |
Shares Issued
|
| |
Total Consideration
|
| |
Average
Price Per |
| | | | | | | |||||||||||||||||||||
| | | |
Number
|
| |
Percent
|
| |
Amount (US$)
|
| |
Percent
|
| |
Share (US$)
|
| | | |||||||||||||||||||
|
Existing shareholders
|
| | | | 1,863,758 | | | | | | 32.4% | | | | | | 51,515,944 | | | | | | 74.6% | | | | | $ | 27.64 | | | | | ||||
|
New investors
|
| | | | 3,888,889 | | | | | | 67.6% | | | | | | 17,500,000 | | | | | | 25.4% | | | | | $ | 4.50 | | | | | ||||
|
Total
|
| | | | 5,752,647 | | | | | | 100% | | | | | | 69,015,944 | | | | | | 100% | | | | | | | | | | | ||||
|
Year
|
| |
Full Time
|
| |
Part Time
|
| |
Total
|
| |||||||||
|
Fiscal year 2023
|
| | | | 24 | | | | | | 2 | | | | | | 26 | | |
|
Fiscal year 2024
|
| | | | 18 | | | | | | 0 | | | | | | 18 | | |
|
Fiscal year 2025
|
| | | | 20 | | | | | | 0 | | | | | | 20 | | |
| | | |
Nine Months Ended September 30,
|
| | | | | | | |||||||||
| | | |
2025
|
| |
2024
|
| |
Change
|
| |||||||||
| | | |
US$
|
| |
US$
|
| |
US$
|
| |||||||||
| Revenue | | | | | | | | | | | | | | | | | | | |
|
HEXWAVE™ revenue
|
| | | | 909,407 | | | | | | 1,447,532 | | | | | | (538,125) | | |
|
Contract revenue
|
| | | | 854,849 | | | | | | 1,250,000 | | | | | | (395,151) | | |
|
Total revenue
|
| | | | 1,764,256 | | | | | | 2,697,532 | | | | | | (933,276) | | |
| Cost of revenue | | | | | | | | | | | | | | | | | | | |
|
HEXWAVE™ cost of revenue
|
| | | | 2,112,884 | | | | | | 2,408,789 | | | | | | 295,905 | | |
|
Contract cost of revenue
|
| | | | 1,493,636 | | | | | | 1,796,912 | | | | | | 303,276 | | |
|
Total cost of revenue
|
| | | | 3,606,520 | | | | | | 4,205,701 | | | | | | (599,181) | | |
|
Gross loss
|
| | | | (1,842,264) | | | | | | (1,508,169) | | | | | | (334,095) | | |
| Operating expenses: | | | | | | | | | | | | | | | | | | | |
|
Engineering and Research and Development
|
| | | | 2,058,666 | | | | | | 1,744,426 | | | | | | 314,237 | | |
|
General and administrative
|
| | | | 6,101,438 | | | | | | 2,599,438 | | | | | | 3,502,000 | | |
|
Total operating expenses
|
| | | | 8,160,104 | | | | | | 4,343,864 | | | | | | 3,816,240 | | |
|
Loss from operations
|
| | | | (10,002,368) | | | | | | (5,852,033) | | | | | | (4,150,335) | | |
|
Other expense (income)
|
| | | | 507,838 | | | | | | 577,694 | | | | | | (69,856) | | |
|
Net loss
|
| | | | (10,510,206) | | | | | | (6,429,727) | | | | | | (4,080,479) | | |
| | | |
Year Ended December 31,
|
| | | | | | | |||||||||
| | | |
2024
|
| |
2023
|
| |
Change
|
| |||||||||
| | | |
US$
|
| |
US$
|
| |
US$
|
| |||||||||
| Revenue | | | | | | | | | | | | | | | | | | | |
|
HEXWAVE™ revenue
|
| | | | 1,013,546 | | | | | | 120,000 | | | | | | 893,546 | | |
|
Contract revenue
|
| | | | 1,425,000 | | | | | | 1,372,557 | | | | | | 52,443 | | |
|
Total revenue
|
| | | | 2,438,546 | | | | | | 1,492,557 | | | | | | 945,989 | | |
| Cost of revenue | | | | | | | | | | | | | | | | | | | |
|
HEXWAVE™ cost of revenue
|
| | | | 2,033,498 | | | | | | 1,546,040 | | | | | | 487,458 | | |
|
Contract cost of revenue
|
| | | | 2,081,971 | | | | | | 1,163,211 | | | | | | 918,760 | | |
|
Total cost of revenue
|
| | | | 4,115,469 | | | | | | 2,709,251 | | | | | | 1,406,218 | | |
|
Gross loss
|
| | | | (1,676,923) | | | | | | (1,216,694) | | | | | | (460,229) | | |
| Operating expenses: | | | | | | | | | | | | | | | | | | | |
|
Engineering and Research and Development
|
| | | | 2,267,739 | | | | | | 4,022,458 | | | | | $ | (1,754,719) | | |
|
General and administrative
|
| | | | 3,489,202 | | | | | | 3,868,191 | | | | | | (378,989) | | |
|
Total operating expenses
|
| | | | 5,756,941 | | | | | | 7,890,649 | | | | | | (2,133,708) | | |
|
Loss from operations
|
| | | | (7,433,864) | | | | | | (9,107,343) | | | | | | 1,673,479 | | |
|
Other expense (income)
|
| | | | 1,411,299 | | | | | | 261,700 | | | | | | 1,149,599 | | |
|
Net loss
|
| | | | (8,845,163) | | | | | | (9,369,043) | | | | | $ | 523,880 | | |
| | | |
Nine Months Ended September 30,
|
| |
Year Ended December 31,
|
| ||||||||||||||||||
| | | |
2025
|
| |
2024
|
| |
2024
|
| |
2023
|
| ||||||||||||
| | | |
US$
|
| |
US$
|
| |
US$
|
| |
US$
|
| ||||||||||||
|
Cash used in operating activities
|
| | | | (8,379,896) | | | | | | (3,072,818) | | | | | | (6,469,264) | | | | | | (5,537,021) | | |
|
Cash used in investing activities
|
| | | | (176,498) | | | | | | (125,206) | | | | | | (121,217) | | | | | | (221,095) | | |
|
Cash provided by financing activities
|
| | | | 7,931,412 | | | | | | 3,474,239 | | | | | | 7,781,755 | | | | | | 5,069,546 | | |
|
Effect of foreign exchange rate changes on cash
|
| | | | 112,660 | | | | | | 113,338 | | | | | | (39,008) | | | | | | 12,060 | | |
|
Net change in cash and cash equivalents
|
| | | | (512,322) | | | | | | 389,553 | | | | | | 1,152,266 | | | | | | (676,510) | | |
| |
Financial assets denominated in foreign currencies
|
| | | US$ | 1,370,259 | | |
| |
Financial liabilities denominated in foreign currencies
|
| | | | (882,206) | | |
| |
Net exposure
|
| | | US$ | 488,053 | | |
|
Name
|
| |
Position
|
|
| Executive Officers: | | | | |
| Jason Burinescu | | | Executive Chairman and Director | |
| William Frain | | | Chief Executive Officer and Director | |
| Bryan Cunningham | | | President | |
| Omar Garcia Abrego | | |
Chief Financial Officer and Corporate Secretary
|
|
| Independent Directors and Independent Director Nominees: | | | | |
| Arjun Grewal | | | Independent Director | |
| Linda Jacksta | | | Independent Director | |
| William W. Hamilton | | | Independent Director Nominee(1) | |
|
Name of Beneficial Owner
|
| |
Common
Shares Held |
| |
Options
|
| |
RSUs
|
| |
Warrants
|
| |
Number of
Common Shares Beneficially Owned |
| |
Percent of
Outstanding Common Shares |
| ||||||||||||||||||
|
Jason Burinescu
|
| | | | — | | | | | | 10,556 | | | | | | — | | | | | | — | | | | | | 10,556 | | | | | | * | | |
|
Bryan Cunningham
|
| | | | 1,778 | | | | | | 3,056 | | | | | | — | | | | | | — | | | | | | 4,834 | | | | | | * | | |
|
William Frain
|
| | | | 5,914(1) | | | | | | 7,111 | | | | | | 2,110 | | | | | | 1,268 | | | | | | 16,404 | | | | | | * | | |
|
Omar Garcia Abrego
|
| | | | 2,883 | | | | | | 4,389 | | | | | | — | | | | | | — | | | | | | 7,272 | | | | | | * | | |
|
Arjun Grewal
|
| | | | — | | | | | | 2,111 | | | | | | 222 | | | | | | — | | | | | | 2,333 | | | | | | * | | |
|
William W. Hamilton
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | * | | |
|
Linda Jacksta
|
| | | | — | | | | | | 2,111 | | | | | | 222 | | | | | | — | | | | | | 2,333 | | | | | | * | | |
|
Total
|
| | | | 10,575 | | | | | | 29,334 | | | | | | 2,554 | | | | | | 1,268 | | | | | | 43,732 | | | | | | 2.20% | | |
|
Nature of Services
|
| |
2025 (C$)
|
| |
2024 (C$)
|
| ||||||
|
Audit Fees(1)
|
| | | | 245,308 | | | | | | 181,019 | | |
|
Audit Related Fees(2)
|
| | | | 60,732 | | | | | | 17,669 | | |
|
Tax Fees(3)
|
| | | | — | | | | | | — | | |
|
All Other Fees(4)
|
| | | | — | | | | | | — | | |
| Total | | | | | 306,040 | | | | | | 198,688 | | |
|
Executive Officer and Director Compensation for 2025 Fiscal Year(1)
|
| ||||||||||||||||||||||||
|
Name and position
|
| |
Salary/Fees(2)
|
| |
Bonus(3)
|
| |
Stock
Options(4) |
| |
Total
Compensation |
| ||||||||||||
|
Jason Burinescu
Executive Chairman and Director |
| | | $ | 25,000 | | | | | | — | | | | | $ | 32,191 | | | | | $ | 129,442 | | |
|
William Frain
Chief Executive Officer and Director |
| | | $ | 278,279 | | | | | $ | 50,000 | | | | | $ | 34,337 | | | | | $ | 433,258 | | |
|
Omar Garcia Abrego
Chief Financial Officer and Corporate Secretary |
| | | $ | 189,426 | | | | | | — | | | | | $ | 51,506 | | | | | $ | 216,368 | | |
|
Arjun Grewal(3)
Director |
| | | $ | 30,000 | | | | | | — | | | | | $ | 12,876 | | | | | $ | 53,875 | | |
|
Linda Lee Jacksta(4)
Director |
| | | $ | 30,000 | | | | | | — | | | | | $ | 12,876 | | | | | $ | 53,875 | | |
|
Daryl Rebeck(5)
Former Executive Chairman |
| | | $ | 27,867 | | | | | | — | | | | | | — | | | | | $ | 27,867 | | |
|
Executive Officer and Director Outstanding Equity Awards
|
| |||||||||||||||||||||
|
Name and Position
|
| |
Type of
Award(1) |
| |
Grant
Date |
| |
Number of
Underlying Common Shares |
| |
Exercise
Price(2) (C$) |
| |
Expiration
Date |
| ||||||
|
Jason Burinescu(3)
Executive Chairman and Director |
| |
Stock Options
|
| |
07/02/2025
|
| | | | 5,556 | | | | | | 11.00 | | | |
07/02/2027
|
|
| |
Stock Options
|
| |
12/30/2024
|
| | | | 7,778 | | | | | | 36.00 | | | |
12/30/2029
|
| ||
|
William Frain(4)
Chief Executive Officer and Director |
| |
RSU
|
| |
10/16/2023
|
| | | | 930 | | | | | | n/a | | | |
10/16/2028
|
|
| |
RSU
|
| |
4/26/2022
|
| | | | 444 | | | | | | n/a | | | |
4/26/2027
|
| ||
| |
RSU
|
| |
6/10/2021
|
| | | | 180 | | | | | | n/a | | | |
6/10/2026
|
| ||
| |
RSU
|
| |
4/7/2021
|
| | | | 556 | | | | | | n/a | | | |
4/7/2026
|
| ||
| |
Stock Options
|
| |
9/9/2025
|
| | | | 4,444 | | | | | | 12.00 | | | |
9/9/2030
|
| ||
| |
Stock Options
|
| |
12/30/2024
|
| | | | 7,778 | | | | | | 36.00 | | | |
12/30/2029
|
| ||
| |
Stock Option
|
| |
4/26/2022
|
| | | | 444 | | | | | | 185.00 | | | |
4/26/2027
|
| ||
| |
Stock Option
|
| |
4/7/2021
|
| | | | 556 | | | | | | 225.00 | | | |
4/7/2026
|
| ||
| |
Operational
Performance Shares |
| |
n/a
|
| | | | 4,444 | | | | | | n/a | | | |
n/a
|
| ||
|
Omar Garcia Abrego(5)
Chief Financial Officer and Corporate Secretary |
| |
Stock Options
|
| |
9/9/2025
|
| | | | 6,667 | | | | | | 12.00 | | | |
9/9/2030
|
|
| |
Stock Options
|
| |
12/30/2024
|
| | | | 1,111 | | | | | | 36.00 | | | |
12/30/2029
|
| ||
| |
Stock Option
|
| |
10/16/2023
|
| | | | 167 | | | | | | n/a | | | |
10/16/2028
|
| ||
| |
Stock Option
|
| |
4/26/2022
|
| | | | 111 | | | | | | 86.00 | | | |
4/26/2027
|
| ||
| |
Stock Option
|
| |
4/7/2021
|
| | | | 222 | | | | | | 185.00 | | | |
4/7/2026
|
| ||
|
Arjun Grewal(6)
Director |
| |
Stock Options
|
| |
9/9/2025
|
| | | | 1,667 | | | | | | 12.00 | | | |
9/9/2030
|
|
| |
RSU
|
| |
10/16/2023
|
| | | | 222 | | | | | | n/a | | | |
10/16/2028
|
| ||
| |
Stock Option
|
| |
12/30/2024
|
| | | | 1,667 | | | | | | 36.00 | | | |
12/30/2029
|
| ||
| |
Stock Option
|
| |
4/26/2022
|
| | | | 167 | | | | | | 185.00 | | | |
4/26/2027
|
| ||
| |
Stock Option
|
| |
4/7/2021
|
| | | | 278 | | | | | | 225.00 | | | |
4/7/2026
|
| ||
|
Linda Lee Jacksta(7)
Director |
| |
RSU
|
| |
10/16/2023
|
| | | | 222 | | | | | | n/a | | | |
10/16/2028
|
|
| |
Stock Options
|
| |
9/9/2025
|
| | | | 1,667 | | | | | | 12.00 | | | |
9/9/2030
|
| ||
| |
Stock Options
|
| |
12/30/2024
|
| | | | 1,667 | | | | | | 36.00 | | | |
12/30/2029
|
| ||
| |
Stock Option
|
| |
4/26/2022
|
| | | | 167 | | | | | | 185.00 | | | |
4/26/2027
|
| ||
| |
Stock Option
|
| |
7/28/2021
|
| | | | 278 | | | | | | 248.00 | | | |
7/28/2026
|
| ||
|
Daryl Rebeck(8)
Former Executive Chairman |
| |
RSU
|
| |
10/16/2023
|
| | | | 667 | | | | | | n/a | | | |
10/16/2028
|
|
| |
RSU
|
| |
4/26/2022
|
| | | | 444 | | | | | | n/a | | | |
4/26/2027
|
| ||
| |
RSU
|
| |
4/7/2021
|
| | | | 556 | | | | | | n/a | | | |
4/7/2026
|
| ||
| |
Stock Option
|
| |
12/30/2024
|
| | | | 7,778 | | | | | | 36.00 | | | |
12/30/2029
|
| ||
| |
Stock Option
|
| |
4/26/2022
|
| | | | 444 | | | | | | 185.00 | | | |
4/26/2027
|
| ||
| |
Stock Option
|
| |
4/7/2021
|
| | | | 556 | | | | | | 225.00 | | | |
4/7/2026
|
| ||
|
Bryan Cunningham
President |
| |
Stock Options
|
| |
9/9/2025
|
| | | | 3,333 | | | | | | 12.00 | | | |
9/9/2030
|
|
| |
Stock Options
|
| |
12/30/2024
|
| | | | 2,778 | | | | | | 36.00 | | | |
12/30/2029
|
| ||
|
Plan Category
|
| |
Number of securities to
be issued upon exercise of outstanding options, deferred share units and restricted share units (a) |
| |
Weighted-average
exercise price of outstanding options, deferred share units and restricted share units (b) |
| |
Number of securities
remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) (c) |
|
|
Equity compensation plans approved by the securityholders – Omnibus Long-Term Incentive Plan
|
| |
Options: 110,834
DSUs: nil RSUs: 15,420 |
| |
Options: C$36.00
DSUs: n/a RSUs: n/a |
| |
63,414 combined
|
|
|
Equity compensation plans not approved by the securityholders
|
| |
n/a
|
| |
n/a
|
| |
n/a
|
|
|
Total
|
| |
Options: 110,834
DSUs: nil RSUs: 15,420 |
| |
Options: C$36.00
DSUs: n/a RSUs: n/a |
| |
63,414 combined
|
|
|
Underwriter
|
| |
Number of
Common Shares |
| |
Number of
Pre-Funded Warrants |
| ||||||
|
The Benchmark Company, LLC
|
| | | | | | | | | | | | |
| | | | | | | | | | | | | | |
|
TOTAL
|
| | | | | | | | | | | ||
| | | |
Total
|
| |||||||||
| | | |
Per
Common Share |
| |
Per
Pre-Funded Warrant |
| |
No Exercise
|
| |
Full Exercise
|
|
|
Initial public offering price
|
| | US$ | | | US$ | | | US$ | | | US$ | |
|
Underwriting discounts and commissions
|
| | US$ | | | US$ | | | US$ | | | US$ | |
|
Proceeds, before expenses, to us(1)
|
| | US$ | | | US$ | | | US$ | | | US$ | |
|
Number of Warrants
|
| |
Exercise
Price (C$) |
| |
Expiry Date
|
| |||
|
340,121
|
| | | $ | 15.75 | | | |
July 28, 2026
|
|
|
39,617
|
| | | $ | 135.00 | | | |
October 5, 2026
|
|
|
1,349
|
| | | $ | 90.00 | | | |
October 5, 2026
|
|
|
45,163
|
| | | $ | 24.75 | | | |
December 18, 2026
|
|
|
11,701
|
| | | $ | 67.95 | | | |
January 12, 2027
|
|
|
337
|
| | | $ | 90.00 | | | |
January 12, 2027
|
|
|
2,222
|
| | | $ | 67.95 | | | |
February 5, 2027
|
|
|
20,202
|
| | | $ | 90.00 | | | |
February 28, 2027
|
|
|
4,715
|
| | | $ | 74.25 | | | |
March 20, 2027
|
|
|
33,678
|
| | | $ | 92.25 | | | |
March 20, 2027
|
|
|
423
|
| | | $ | 90.00 | | | |
June 27, 2027
|
|
|
10,334
|
| | | $ | 67.95 | | | |
August 13, 2027
|
|
|
3,215
|
| | | $ | 123.75 | | | |
October 27, 2027
|
|
|
21,296
|
| | | $ | 225.00 | | | |
October 27, 2027
|
|
|
176,482
|
| | | $ | 13.50 | | | |
December 31, 2027
|
|
|
7,915
|
| | | $ | 13.50 | | | |
December 31, 2027
|
|
|
87,627
|
| | | $ | 13.50 | | | |
January 15, 2028
|
|
|
5,045
|
| | | $ | 13.50 | | | |
January 15, 2028
|
|
|
Number of Options
|
| |
Exercise
Price (C$) |
| |
Expiry Date
|
| |||
|
1,844
|
| | | $ | 225.00 | | | |
April 7, 2026
|
|
|
278
|
| | | $ | 247.50 | | | |
July 28, 2026
|
|
|
111
|
| | | $ | 292.50 | | | |
July 28, 2026
|
|
|
945
|
| | | $ | 207.00 | | | |
November 1, 2026
|
|
|
222
|
| | | $ | 162.00 | | | |
January 14, 2027
|
|
|
1,111
|
| | | $ | 26.55 | | | |
April 15, 2027
|
|
|
2,634
|
| | | $ | 184.50 | | | |
April 26, 2027
|
|
|
133
|
| | | $ | 99.00 | | | |
November 21, 2027
|
|
|
111
|
| | | $ | 81.00 | | | |
April 26, 2028
|
|
|
1,778
|
| | | $ | 85.50 | | | |
October 16, 2028
|
|
|
51,667
|
| | | $ | 36.00 | | | |
December 30, 2029
|
|
|
3,333
|
| | | $ | 37.80 | | | |
April 30, 2030
|
|
|
5,556
|
| | | $ | 10.80 | | | |
July 2, 2027
|
|
|
41,111
|
| | | $ | 11.93 | | | |
September 9, 2030
|
|
|
Number of RSUs(1)
|
| |
Exercise
Price (C$) |
| |
Expiry Date
|
| |||
|
556
|
| | | | n/a | | | |
April 7, 2026
|
|
|
464
|
| | | | n/a | | | |
June 10, 2026
|
|
|
333
|
| | | | n/a | | | |
January 14, 2027
|
|
|
222
|
| | | | n/a | | | |
April 24, 2027
|
|
|
2,974
|
| | | | n/a | | | |
October 16, 2028
|
|
|
2,612
|
| | | | n/a | | | |
February 28, 2029
|
|
|
1,111
|
| | | | n/a | | | |
January 1, 2029
|
|
|
7,149
|
| | | | n/a | | | |
December 12, 2029
|
|
|
Item
|
| |
Amount
|
|
|
SEC registration fee
|
| |
US$ 2,779.26
|
|
|
FINRA filing fee
|
| |
US$ 3,518.75
|
|
|
Nasdaq listing fee
|
| |
US$ 50,000.00
|
|
|
Printing and engraving expenses
|
| |
US$ 180,000.00
|
|
|
Legal fees and expenses
|
| |
US$ 900,000.00
|
|
|
Accounting fees and expenses
|
| |
US$ 66,666.00
|
|
|
Miscellaneous expenses(1)
|
| |
US$ 189,171.71
|
|
|
Total
|
| |
US$1,392,135.72
|
|
| | Consolidated Financial Statements for the Years Ended December 31, 2024 and 2023 | | | | | | | |
| | | | | | F-2 | | | |
| | | | | | F-3 | | | |
| | | | | | F-4 | | | |
| | | | | | F-5 | | | |
| | | | | | F-6 | | | |
| | | | | | F-8 | | | |
| |
Amended and Restated Condensed Consolidated Interim Financial Statements for the Three and Nine Months Ended September 30, 2025 and 2024
|
| | | | | | |
| | | | | | F-49 | | | |
| | | | | | F-50 | | | |
| | | | | | F-51 | | | |
| | | | | | F-52 | | | |
| | | | | | F-53 | | |
|
As at:
|
| |
Note
|
| |
December 31,
2024 |
| |
December 31,
2023 |
| ||||||
| | | | | | |
$
|
| |
$
|
| ||||||
| Assets | | | | | | | | | | | | | | | | |
| Current assets: | | | | | | | | | | | | | | | | |
|
Cash
|
| | | | | | | 1,153,229 | | | | | | 963 | | |
|
Accounts receivable, prepaids and deposits
|
| |
4
|
| | | | 1,664,376 | | | | | | 257,885 | | |
|
Inventory
|
| |
5
|
| | | | 868,314 | | | | | | 1,255,077 | | |
|
Contract costs
|
| |
16
|
| | | | 268,952 | | | | | | — | | |
|
Lease receivable
|
| |
11
|
| | | | — | | | | | | 7,048 | | |
| | | | | | | | | 3,954,871 | | | | | | 1,520,973 | | |
| Non-current assets: | | | | | | | | | | | | | | | | |
|
Property and equipment
|
| |
6
|
| | | | 759,937 | | | | | | 1,043,876 | | |
|
Intangible assets
|
| |
7
|
| | | | 2,571,693 | | | | | | 3,266,803 | | |
| | | | | | | | | 3,331,630 | | | | | | 4,310,679 | | |
|
Total assets
|
| | | | | | | 7,286,501 | | | | | | 5,831,652 | | |
| Liabilities | | | | | | | | | | | | | | | | |
| Current liabilities: | | | | | | | | | | | | | | | | |
|
Accounts payable and accrued liabilities
|
| |
18
|
| | | | 4,155,890 | | | | | | 3,862,675 | | |
|
Loans payable
|
| |
8 & 18
|
| | | | 100,907 | | | | | | 530,062 | | |
|
Parabilis term-loan
|
| |
9
|
| | | | 983,476 | | | | | | — | | |
|
Factoring liability
|
| |
10
|
| | | | 983,671 | | | | | | 1,107,347 | | |
|
Deferred revenue
|
| |
15
|
| | | | 180,000 | | | | | | 180,000 | | |
|
CEBA loan
|
| |
8
|
| | | | — | | | | | | 29,445 | | |
|
Lease liabilities
|
| |
11
|
| | | | 203,443 | | | | | | 247,412 | | |
| | | | | | | | | 6,607,387 | | | | | | 5,956,941 | | |
| Non-current liabilities: | | | | | | | | | | | | | | | | |
|
Non-current lease liabilities
|
| |
11
|
| | | | 505,382 | | | | | | 639,173 | | |
|
Non-current Parabilis term loan
|
| |
9
|
| | | | 938,211 | | | | | | — | | |
|
Total liabilities
|
| | | | | | | 8,050,980 | | | | | | 6,596,114 | | |
| Shareholders’ deficiency | | | | | | | | | | | | | | | | |
|
Share capital
|
| |
12
|
| | | | 40,717,157 | | | | | | 32,565,254 | | |
|
Share subscriptions received in advance
|
| |
12
|
| | | | — | | | | | | 224,915 | | |
|
Equity reserves
|
| |
13
|
| | | | 4,872,472 | | | | | | 4,146,489 | | |
|
Accumulated other comprehensive income (loss)
|
| | | | | | | (28,896) | | | | | | (221,071) | | |
|
Deficit
|
| | | | | | | (46,325,212) | | | | | | (37,480,049) | | |
|
Total shareholders’ deficiency
|
| | | | | | | (764,479) | | | | | | (764,462) | | |
|
Total liabilities and shareholders’ deficiency
|
| | | | | | | 7,286,501 | | | | | | 5,831,652 | | |
| |
“William Frain”
Director |
| |
“Jason Burinescu”
Director |
|
| | | |
Note
|
| |
Years ended December 31,
|
| |||||||||
| |
2024
|
| |
2023
|
| |||||||||||
| | | | |
$
|
| |
$
|
| ||||||||
|
Revenue
|
| |
15 & 16
|
| | | | | | | | | | | | |
|
HEXWAVE revenue
|
| | | | | | $ | 1,013,546 | | | | | $ | 120,000 | | |
|
Contract revenue
|
| | | | | | | 1,425,000 | | | | | | 1,372,557 | | |
|
Total Revenue
|
| | | | | | | 2,438,546 | | | | | | 1,492,557 | | |
| Cost of revenue | | | | | | | | | | | | | | | | |
|
HEXWAVE cost of revenue
|
| | | | | | | 2,033,498 | | | | | | 1,546,040 | | |
|
Contract cost of revenue
|
| | | | | | | 2,081,971 | | | | | | 1,163,211 | | |
|
Total cost of revenue
|
| | | | | | | 4,115,469 | | | | | | 2,709,251 | | |
|
Gross loss
|
| | | | | | | (1,676,923) | | | | | | (1,216,694) | | |
| Engineering and Research and Development Expenses: | | | | | | | | | | | | | | | | |
|
Product development & technology costs
|
| | | | | | | 148,675 | | | | | | 370,073 | | |
|
Salaries and consulting fees
|
| |
18
|
| | | | 1,655,580 | | | | | | 2,766,601 | | |
|
Stock-based compensation
|
| |
13 & 18
|
| | | | 98,008 | | | | | | 89,302 | | |
|
Depreciation
|
| |
6
|
| | | | 248,979 | | | | | | 526,686 | | |
|
Office, rent & administration, travel and miscellaneous
|
| | | | | | | 116,497 | | | | | | 269,796 | | |
| General & Administration Expenses | | | | | | | | | | | | | | | | |
|
Salaries and consulting fees
|
| |
18
|
| | | | 1,809,724 | | | | | | 1,482,860 | | |
|
Legal and professional fees
|
| | | | | | | 458,390 | | | | | | 299,011 | | |
|
Stock-based compensation
|
| |
13 & 18
|
| | | | 255,220 | | | | | | 511,699 | | |
|
Office, rent & administration, travel, and miscellaneous
|
| | | | | | | 965,868 | | | | | | 1,574,621 | | |
| | | | | | | | | 5,756,941 | | | | | | 7,890,649 | | |
|
Operating Loss
|
| | | | | | $ | (7,433,864) | | | | | $ | (9,107,343) | | |
| Other expense (income): | | | | | | | | | | | | | | | | |
|
Other expense (income)
|
| |
12
|
| | | | 589,550 | | | | | | (3,078) | | |
|
Interest expense
|
| | | | | | | 808,989 | | | | | | 283,247 | | |
|
Foreign exchange loss (gain)
|
| | | | | | | 12,760 | | | | | | (18,469) | | |
| | | | | | | | | 1,411,299 | | | | | | 261,700 | | |
|
Net loss for the year
|
| | | | | | | (8,845,163) | | | | | | (9,369,043) | | |
| Other comprehensive loss | | | | | | | | | | | | | | | | |
|
Items that may be reclassified subsequently to profit or (loss)
|
| | | | | | | | | | | | | | | |
|
Foreign currency translation adjustment
|
| | | | | | | 192,175 | | | | | | 31,598 | | |
|
Total loss and comprehensive loss for the year
|
| | | | | | | (8,652,988) | | | | | | (9,337,445) | | |
| Weighted average number of common shares outstanding: | | | | | | | | | | | | | | | | |
|
Basic and diluted
|
| | | | | | | 381,350 | | | | | | 284,812 | | |
| Loss per share: | | | | | | | | | | | | | | | | |
|
Basic and diluted loss per common share
|
| |
14
|
| | | | (23.19) | | | | | | (32.90) | | |
| | | |
Note
|
| |
Number of
common shares |
| |
Share
capital |
| |
Equity
reserves |
| |
Share
subscriptions received in advance |
| |
Accumulated
other comprehensive income (loss) |
| |
Deficit
|
| |
Total
|
| |||||||||||||||||||||
| | | | | | | | | | | | |
$
|
| |
$
|
| |
$
|
| |
$
|
| |
$
|
| |
$
|
| ||||||||||||||||||
|
Balance as at December 31, 2022
|
| | | | | | | 259,644 | | | | | | 28,936,296 | | | | | | 3,518,365 | | | | | | — | | | | | | (252,669) | | | | | | (28,111,006) | | | | | | 4,090,986 | | |
|
Private placement, net of share issue cost
|
| |
12
|
| | | | 63,530 | | | | | | 3,656,081 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 3,656,081 | | |
|
Share subscriptions received in advance
|
| |
12
|
| | | | — | | | | | | — | | | | | | — | | | | | | 224,915 | | | | | | — | | | | | | — | | | | | | 224,915 | | |
|
Fair value of compensation warrants
|
| |
12
|
| | | | — | | | | | | (48,729) | | | | | | 48,729 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
|
Fair value of warrants allocated to share capital on expiry
|
| |
12
|
| | | | — | | | | | | 396,285 | | | | | | (396,285) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
|
Residual value allocated to
warrants |
| |
12
|
| | | | — | | | | | | (374,679) | | | | | | 374,679 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
|
Stock based compensation
|
| |
13
|
| | | | — | | | | | | — | | | | | | 601,001 | | | | | | — | | | | | | — | | | | | | — | | | | | | 601,001 | | |
|
Foreign currency translation adjustment
|
| | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 31,598 | | | | | | — | | | | | | 31,598 | | |
|
Loss for the year
|
| | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (9,369,043) | | | | | | (9,369,043) | | |
|
Balance as at December 31, 2023
|
| | | | | | | 323,174 | | | | | | 32,565,254 | | | | | | 4,146,489 | | | | | | 224,915 | | | | | | (221,071) | | | | | | (37,480,049) | | | | | | (764,462) | | |
|
Balance as at December 31, 2023
|
| | | | | | | 323,174 | | | | | | 32,565,254 | | | | | | 4,146,489 | | | | | | 224,915 | | | | | | (221,071) | | | | | | (37,480,049) | | | | | | (764,462) | | |
|
Private placement, net of share issue cost
|
| |
12
|
| | | | 601,427 | | | | | | 7,478,484 | | | | | | — | | | | | | (224,915) | | | | | | — | | | | | | — | | | | | | 7,253,569 | | |
|
Expired broker warrants allocated to share capital on expiry
|
| |
12
|
| | | | — | | | | | | 312,815 | | | | | | (312,815) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
|
Residual value allocated to
warrants |
| |
12
|
| | | | — | | | | | | (562,251) | | | | | | 562,251 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
|
Residual value of warrants exercised
|
| |
12
|
| | | | — | | | | | | 15,275 | | | | | | (15,275) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
|
Fair value of broker warrants
|
| |
12
|
| | | | — | | | | | | (393,138) | | | | | | 393,138 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
|
Warrants exercised for cash
|
| |
12
|
| | | | 1,333 | | | | | | 87,367 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 87,367 | | |
|
Shares issued on debt settlement
|
| |
12
|
| | | | 34,722 | | | | | | 927,332 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 927,332 | | |
|
Restricted shares units exercised
|
| |
12
|
| | | | 2,263 | | | | | | 286,019 | | | | | | (286,019) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
|
Stock based compensation
|
| |
13
|
| | | | — | | | | | | — | | | | | | 384,703 | | | | | | — | | | | | | — | | | | | | — | | | | | | 384,703 | | |
|
Foreign currency translation adjustment
|
| | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 192,175 | | | | | | — | | | | | | 192,175 | | |
|
Loss for the year
|
| | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (8,845,163) | | | | | | (8,845,163) | | |
|
Balance as at December 31, 2024
|
| | | | | | | 962,919 | | | | | | 40,717,157 | | | | | | 4,872,472 | | | | | | — | | | | | | (28,896) | | | | | | (46,325,212) | | | | | | (764,479) | | |
| | | |
Years ended December 31,
|
| |||||||||
| | | |
2024
|
| |
2023
|
| ||||||
| | | |
$
|
| |
$
|
| ||||||
| Cash (used in) provided by: | | | | | | | | | | | | | |
| Operating activities: | | | | | | | | | | | | | |
|
Loss and comprehensive loss for the year
|
| | | | (8,845,163) | | | | | | (9,369,043) | | |
|
Items not involving cash:
|
| | | | | | | | | | | | |
|
Lease liability interest
|
| | | | 69,652 | | | | | | 80,049 | | |
|
Accrued interest
|
| | | | 294,304 | | | | | | 222,497 | | |
|
Depreciation
|
| | | | 396,315 | | | | | | 593,169 | | |
|
Amortization recorded in cost of revenue
|
| | | | 922,221 | | | | | | 695,465 | | |
|
Loss of settlement of debt
|
| | | | 563,996 | | | | | | — | | |
|
Loss on disposal of property and equipment
|
| | | | 29,233 | | | | | | — | | |
|
Stock based compensation
|
| | | | 384,703 | | | | | | 601,001 | | |
|
Impairment of inventory
|
| | | | 233,568 | | | | | | 344,158 | | |
|
Impairment of contract costs
|
| | | | 115,730 | | | | | | — | | |
|
Factoring fees
|
| | | | 289,684 | | | | | | — | | |
|
Credit Line Parabilis fees
|
| | | | 74,449 | | | | | | — | | |
|
Foreign exchange
|
| | | | 230,974 | | | | | | — | | |
|
Changes in non-cash working capital:
|
| | | | | | | | | | | | |
|
Amounts receivable and prepaids
|
| | | | (1,406,491) | | | | | | 56,808 | | |
|
Inventory
|
| | | | 105,692 | | | | | | (1,200,199) | | |
|
Contract costs
|
| | | | (384,682) | | | | | | — | | |
|
Accounts payable and accrued liabilities
|
| | | | 456,551 | | | | | | 2,259,074 | | |
|
Deferred revenue
|
| | | | — | | | | | | 180,000 | | |
|
Cash used in operating activities
|
| | | | (6,469,264) | | | | | | (5,537,021) | | |
| Investing activities: | | | | | | | | | | | | | |
|
Additions to intangible assets
|
| | | | (27,111) | | | | | | (111,232) | | |
|
Additions to property and equipment
|
| | | | (94,106) | | | | | | (109,863) | | |
|
Cash used in investing activities
|
| | | | (121,217) | | | | | | (221,095) | | |
| Financing activities: | | | | | | | | | | | | | |
|
Proceeds from issuance of units, net of share issue costs
|
| | | | 6,989,017 | | | | | | 3,656,081 | | |
|
Proceeds from share subscriptions received in advance
|
| | | | — | | | | | | 224,915 | | |
|
Proceeds from Parabilis term loan
|
| | | | 1,800,000 | | | | | | — | | |
|
Proceeds from Parabilis credit line
|
| | | | 1,551,166 | | | | | | — | | |
|
Repayments from Parabilis credit line
|
| | | | (641,944) | | | | | | — | | |
|
Proceeds from working capital loans – Related Parties
|
| | | | 82,000 | | | | | | 140,089 | | |
|
Repayments of working capital loans – Related Parties
|
| | | | (71,485) | | | | | | — | | |
|
Proceeds from working capital loans
|
| | | | 927,555 | | | | | | 1,573,627 | | |
|
Repayments of working capital loans
|
| | | | (1,274,405) | | | | | | (1,213,966) | | |
| | | |
Years ended December 31,
|
| |||||||||
| | | |
2024
|
| |
2023
|
| ||||||
| | | |
$
|
| |
$
|
| ||||||
|
Proceeds from factoring
|
| | | | — | | | | | | 1,265,132 | | |
|
Repayments on factoring
|
| | | | (1,397,031) | | | | | | (349,970) | | |
|
Repayment of CEBA loan
|
| | | | (30,121) | | | | | | — | | |
|
Proceeds from warrants exercised
|
| | | | 87,367 | | | | | | — | | |
|
Lease receivable collected
|
| | | | 7,048 | | | | | | 20,827 | | |
|
Repayment of leases liabilities
|
| | | | (247,412) | | | | | | (247,189) | | |
|
Cash provided by financing activities
|
| | | | 7,781,755 | | | | | | 5,069,546 | | |
|
Effect of foreign exchange rate changes on cash
|
| | | | (39,008) | | | | | | 12,060 | | |
|
Effect of foreign exchange rate changes on cash
|
| | | | (39,008) | | | | | | 12,060 | | |
|
Increase (decrease) in cash
|
| | | | 1,152,266 | | | | | | (676,510) | | |
|
Cash, beginning of the year
|
| | | | 963 | | | | | | 677,473 | | |
|
Cash, end of the year
|
| | | | 1,153,229 | | | | | | 963 | | |
| | |||||||||||||
| | Supplemental cash flow information | | | | | | | | | | | | | |
| |
Fair value of compensation brokers warrants
|
| | | $ | 393,138 | | | | | $ | 48,729 | | |
| |
Fair value of shares issued for corporate finance fee
|
| | | | — | | | | | | 79,299 | | |
| |
Residual value allocated to warrants
|
| | | | 562,251 | | | | | | 374,679 | | |
| |
ROU asset additions
|
| | | | — | | | | | | 414,562 | | |
| |
PP&E included in accounts payable
|
| | | | — | | | | | | 24,526 | | |
| |
Inventory transfer to PP&E
|
| | | | 47,503 | | | | | | 86,566 | | |
| |
Intangible assets included in accounts payable
|
| | | | 200,000 | | | | | | 162,407 | | |
| |
Fair value on expiry of warrants
|
| | | | 312,815 | | | | | | 396,285 | | |
| |
Restricted share units exercised
|
| | | | 286,019 | | | | | | — | | |
| |
Fair value of warrants exercised
|
| | | | 15,275 | | | | | | — | | |
| |
Loans settled with private placement proceeds
|
| | | | 264,552 | | | | | | — | | |
|
Subsidiary
|
| |
Place of
Incorporation |
| |
Functional
Currency |
| |
Beneficial
Interest |
| ||||||
|
Liberty Defense Technologies, Inc. (“LDT”)
|
| |
United States
|
| | | | USD | | | | | | 100% | | |
|
DrawDown Detection, Inc. (“DDD”)
|
| |
Canada
|
| | | | CAD | | | | | | 100% | | |
|
LDH GS Amalco Corp.
|
| |
Canada
|
| | | | CAD | | | | | | 100% | | |
|
DrawDown Technologies, Inc. (“DDT”)
|
| |
United States
|
| | | | CAD | | | | | | 100% | | |
|
Asset
|
| |
Life
|
|
| Leasehold improvements | | | The term of the lease | |
| Equipment | | | Three to seven years | |
| Prototypes | | | One year | |
|
Asset
|
| |
Life
|
|
| MIT License | | | Fourteen years | |
| Battelle License | | | Three years | |
| Intellectual Property | | | Seven years | |
|
Financial assets/liabilities
|
| |
Classification IFRS 9
|
|
| Cash | | |
Amortized cost
|
|
| Accounts receivable | | |
Amortized cost
|
|
| Lease receivable | | |
Amortized cost
|
|
| Accounts payable and accrued liabilities | | |
Amortized cost
|
|
| CEBA loan | | |
Amortized cost
|
|
| Loans payable | | |
Amortized cost
|
|
| Parabilis term loan | | |
Amortized cost
|
|
| Factoring liability | | |
Amortized cost
|
|
| Lease liabilities | | |
Amortized cost
|
|
| | | |
December 31,
2024 |
| |
December 31,
2023 |
| ||||||
|
Accounts receivable
|
| | | $ | 255,148 | | | | | $ | 25,494 | | |
|
Prepaids and deposits
|
| | | | 1,409,228 | | | | | | 232,391 | | |
| | | | | $ | 1,664,376 | | | | | $ | 257,885 | | |
| | | |
December 31,
2024 |
| |
December 31,
2023 |
| ||||||
|
Raw materials
|
| | | $ | 211,553 | | | | | $ | 734,824 | | |
|
Work-in-progress
|
| | | | 128,761 | | | | | | 467,940 | | |
|
Finished goods
|
| | | | — | | | | | | 52,313 | | |
|
Right of return on finished goods
|
| | | | 528,000 | | | | | | — | | |
| | | | | $ | 868,314 | | | | | $ | 1,255,077 | | |
| | | |
Equipment
|
| |
Right of Use
Asset |
| |
Prototype
|
| |
Construction in
Process |
| |
Total
|
| |||||||||||||||
| Cost | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
At December 31, 2022
|
| | | $ | 222,954 | | | | | $ | 772,312 | | | | | $ | 584,859 | | | | | $ | 88,715 | | | | | $ | 1,668,840 | | |
|
Additions
|
| | | | — | | | | | | 414,562 | | | | | | 86,556 | | | | | | 134,389 | | | | | | 635,507 | | |
|
Transfers
|
| | | | — | | | | | | — | | | | | | 171,899 | | | | | | (171,899) | | | | | | — | | |
|
At December 31, 2023
|
| | | $ | 222,954 | | | | | $ | 1,186,874 | | | | | $ | 843,314 | | | | | $ | 51,205 | | | | | $ | 2,304,347 | | |
|
Additions
|
| | | | 25,241 | | | | | | — | | | | | | 48,185 | | | | | | 68,183 | | | | | | 141,609 | | |
|
Disposals
|
| | | | — | | | | | | — | | | | | | (116,933) | | | | | | — | | | | | | (116,933) | | |
|
At December 31, 2024
|
| | | $ | 248,195 | | | | | $ | 1,186,874 | | | | | $ | 774,566 | | | | | $ | 119,388 | | | | | $ | 2,329,023 | | |
| Accumulated Depreciation | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
At December 31, 2022
|
| | | $ | 71,717 | | | | | $ | 234,982 | | | | | $ | 360,662 | | | | | $ | — | | | | | $ | 667,361 | | |
|
Depreciation for the year
|
| | | | 59,059 | | | | | | 192,581 | | | | | | 341,529 | | | | | | — | | | | | | 593,169 | | |
|
At December 31, 2023
|
| | | $ | 130,776 | | | | | $ | 427,563 | | | | | $ | 702,191 | | | | | $ | — | | | | | $ | 1,260,530 | | |
|
Depreciation for disposal
|
| | | | — | | | | | | — | | | | | | (87,700) | | | | | | | | | | | | (87,700) | | |
|
Depreciation for the year
|
| | | | 58,788 | | | | | | 189,499 | | | | | | 148,028 | | | | | | — | | | | | | 396,315 | | |
|
At December 31, 2024
|
| | | $ | 189,564 | | | | | $ | 617,062 | | | | | $ | 762,519 | | | | | $ | — | | | | | $ | 1,569,145 | | |
| Foreign exchange movement | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
At December 31, 2023
|
| | | $ | — | | | | | $ | 59 | | | | | $ | — | | | | | $ | — | | | | | $ | 59 | | |
|
At December 31, 2024
|
| | | $ | — | | | | | $ | 59 | | | | | $ | — | | | | | $ | — | | | | | $ | 59 | | |
| Net Book Value | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
At December 31, 2023
|
| | | $ | 92,178 | | | | | $ | 759,370 | | | | | $ | 141,123 | | | | | $ | 51,205 | | | | | $ | 1,043,876 | | |
|
At December 31, 2024
|
| | | $ | 58,631 | | | | | $ | 569,871 | | | | | $ | 12,047 | | | | | $ | 119,388 | | | | | $ | 759,937 | | |
| | | |
MIT
license |
| |
Battelle
license |
| |
Intellectual
property |
| |
Total
|
| ||||||||||||
|
Balance, December 31, 2022
|
| | | $ | 441,225 | | | | | $ | 59,430 | | | | | $ | 3,229,808 | | | | | $ | 3,730,463 | | |
|
Additions
|
| | | | — | | | | | | 231,805 | | | | | | — | | | | | | 231,805 | | |
|
Amortization
|
| | | | (34,108) | | | | | | (67,985) | | | | | | (593,372) | | | | | | (695,465) | | |
|
Balance, December 31, 2023
|
| | | $ | 407,117 | | | | | $ | 223,250 | | | | | $ | 2,636,436 | | | | | $ | 3,266,803 | | |
|
Additions
|
| | | | — | | | | | | 227,111 | | | | | | — | | | | | | 227,111 | | |
|
Amortization
|
| | | | (34,108) | | | | | | (450,361) | | | | | | (437,752) | | | | | | (922,221) | | |
|
Balance, December 31, 2024
|
| | | $ | 373,009 | | | | | $ | — | | | | | $ | 2,198,684 | | | | | $ | 2,571,693 | | |
| | | |
Amounts
|
| |||
|
Year 2021 (paid)
|
| | | $ | 50,000 | | |
|
Year 2022 (paid)
|
| | | | 50,000 | | |
|
Year 2023 (payable)
|
| | | | 100,000 | | |
|
Year 2024 and each year thereafter (payable)
|
| | | | 200,000 | | |
| | | |
Amounts
|
| |||
|
Balance, December 31, 2022
|
| | | $ | — | | |
|
Additions
|
| | | | 1,381,120 | | |
|
Repayments
|
| | | | (1,052,426) | | |
|
Balance, December 31, 2023
|
| | | $ | 328,694 | | |
|
Additions
|
| | | | 82,000 | | |
|
Repayments
|
| | | | (336,037) | | |
|
Balance, December 31, 2024
|
| | | $ | 74,657 | | |
| | | |
Total
|
| |||
|
Balance, December 31, 2022
|
| | | $ | — | | |
|
Additions
|
| | | | 332,596 | | |
|
Repayments
|
| | | | (161,540) | | |
|
Accrued Interest
|
| | | | 30,312 | | |
|
Balance, December 31, 2023
|
| | | $ | 201,368 | | |
|
Additions
|
| | | | 1,053,569 | | |
|
Repayments
|
| | | | (1,260,419) | | |
|
Accrued Interest
|
| | | | 31,732 | | |
|
Balance, December 31, 2024
|
| | | $ | 26,250 | | |
| | | |
Amounts
|
| |||
|
Balance, December 31, 2022 and 2023
|
| | | $ | — | | |
|
Additions
|
| | | | 1,800,000 | | |
|
Interest and fees
|
| | | | 121,687 | | |
|
Balance, December 31, 2024
|
| | | $ | 1,921,687 | | |
|
Current
|
| | | $ | 983,476 | | |
|
Non-Current
|
| | | $ | 938,211 | | |
| | | |
Amounts
|
| |||
|
Balance, December 31, 2022 and 2023
|
| | | $ | — | | |
|
Additions
|
| | | | 1,551,166 | | |
|
Accrued factoring Fee
|
| | | | 74,449 | | |
|
Repayments
|
| | | | (641,944) | | |
|
Balance, December 31, 2024
|
| | | $ | 983,671 | | |
| | | |
Amounts
|
| |||
|
Balance, December 31, 2022
|
| | | $ | — | | |
|
Additions
|
| | | | 1,265,132 | | |
|
Accrued factoring Fee
|
| | | | 192,185 | | |
|
Repayments
|
| | | | (349,970) | | |
|
Balance, December 31, 2023
|
| | | $ | 1,107,347 | | |
|
Accrued factoring Fee
|
| | | | 289,684 | | |
|
Repayments
|
| | | | (1,397,031) | | |
|
Balance, December 31, 2024
|
| | | $ | — | | |
| | | |
Right of
use liability |
| |||
|
Balance, December 31, 2022
|
| | | $ | 638,306 | | |
|
Additions
|
| | | | 414,562 | | |
|
Finance costs
|
| | | | 81,032 | | |
|
Lease payments
|
| | | | (247,189) | | |
|
Foreign exchange movement
|
| | | | (126) | | |
|
Balance, December 31, 2023
|
| | | $ | 886,585 | | |
|
Finance costs
|
| | | | 69,652 | | |
|
Lease payments
|
| | | | (247,412) | | |
|
Balance, December 31, 2024
|
| | | $ | 708,825 | | |
| | | |
December 31,
2024 |
| |
December 31,
2023 |
| ||||||
| Maturity analysis – contractual undiscounted cash flows | | | | | | | | | | | | | |
|
One year or less
|
| | | $ | 257,461 | | | | | $ | 247,412 | | |
|
Two to five years
|
| | | | 558,358 | | | | | | 815,820 | | |
|
Six and thereafter
|
| | | | — | | | | | | — | | |
|
Total lease liabilities
|
| | | $ | 815,819 | | | | | $ | 1,063,232 | | |
|
Lease liabilities included in the statement of financial position
|
| | | $ | 708,825 | | | | | $ | 886,585 | | |
|
Current
|
| | | $ | 203,443 | | | | | $ | 247,412 | | |
|
Non-current
|
| | | $ | 505,382 | | | | | $ | 639,173 | | |
| | | |
Amounts
|
| |||
|
Balance, December 31, 2022
|
| | | $ | 26,837 | | |
|
Accretion
|
| | | | 983 | | |
|
Payments received
|
| | | | (20,827) | | |
|
Foreign exchange movement
|
| | | | 55 | | |
|
Balance, December 31, 2023
|
| | | $ | 7,048 | | |
|
Accretion
|
| | | | 78 | | |
|
Payments received
|
| | | | (6,928) | | |
|
Foreign exchange movement
|
| | | | (198) | | |
|
Balance, December 31, 2024
|
| | | $ | — | | |
| | | |
Number of
stock options |
| |
Weighted
average |
| |||
|
Outstanding, December 31, 2022
|
| | | | 12,566 | | | |
CAD$252.90
|
|
|
Cancelled
|
| | | | (467) | | | |
193.95
|
|
|
Granted
|
| | | | 2,767 | | | |
85.50
|
|
|
Outstanding, December 31, 2023
|
| | | | 14,866 | | | |
CAD$222.30
|
|
|
Cancelled
|
| | | | (1,650) | | | |
195.75
|
|
|
Expired
|
| | | | (1,832) | | | |
558.90
|
|
|
Granted
|
| | | | 60,333 | | | |
36.00
|
|
|
Outstanding, December 31, 2024
|
| | | | 71,717 | | | |
CAD$ 58.05
|
|
| | | |
Outstanding
|
| |
Exercise able
|
| ||||||||||||||||||
|
Expiry date
|
| |
Number of stock
options |
| |
Exercise price
|
| |
Remaining
contractual life (years) |
| |
Number of stock
options |
| ||||||||||||
|
07-Apr-26
|
| | | | 2,623 | | | | | CAD$ | 225.00 | | | | | | 1.27 | | | | | | 2,623 | | |
|
10-Jun-26
|
| | | | 222 | | | | | CAD$ | 225.00 | | | | | | 1.44 | | | | | | 222 | | |
|
28-Jul-26
|
| | | | 278 | | | | | CAD$ | 247.50 | | | | | | 1.57 | | | | | | 278 | | |
|
28-Jul-26
|
| | | | 200 | | | | | CAD$ | 292.50 | | | | | | 1.57 | | | | | | 200 | | |
|
01-Nov-26
|
| | | | 1,033 | | | | | CAD$ | 207.00 | | | | | | 1.84 | | | | | | 1,033 | | |
|
14-Jan-27
|
| | | | 222 | | | | | CAD$ | 162.00 | | | | | | 2.04 | | | | | | 222 | | |
|
26-Apr-27
|
| | | | 3,411 | | | | | CAD$ | 184.50 | | | | | | 2.32 | | | | | | 3,411 | | |
|
26-May-27
|
| | | | 222 | | | | | CAD$ | 171.00 | | | | | | 2.40 | | | | | | 222 | | |
|
16-Aug-27
|
| | | | 411 | | | | | CAD$ | 130.50 | | | | | | 2.62 | | | | | | 411 | | |
|
21-Nov-27
|
| | | | 133 | | | | | CAD$ | 99.00 | | | | | | 2.89 | | | | | | 133 | | |
|
26-Apr-28
|
| | | | 211 | | | | | CAD$ | 81.00 | | | | | | 3.32 | | | | | | 158 | | |
|
16-Oct-28
|
| | | | 2,418 | | | | | CAD$ | 85.50 | | | | | | 3.79 | | | | | | 1,208 | | |
|
30-Dec-29
|
| | | | 60,333 | | | | | CAD$ | 36.00 | | | | | | 4.99 | | | | | | — | | |
|
December 31, 2024
|
| | | | 71,717 | | | | | | | | | | | | | | | | | | 10,121 | | |
| | | |
December 31,
2024 |
| |
December 31,
2023 |
|
|
Risk-free interest rate
|
| |
3.04%
|
| |
4.16%
|
|
|
Expected dividend yield
|
| |
Nil
|
| |
Nil
|
|
|
Stock price volatility
|
| |
145.18%
|
| |
80.98%
|
|
|
Expected life (in years)
|
| |
5 years
|
| |
5 years
|
|
|
Stock price
|
| |
CAD$38.25
|
| |
CAD$49.50
|
|
| | | |
Number of
equity settled RSUs |
| |
Grant Price
|
| ||||||
|
Outstanding, December 31, 2022
|
| | | | 5,494 | | | | | CAD$ | 226.80 | | |
|
Granted
|
| | | | 7,682 | | | | | | 76.50 | | |
|
Outstanding, December 31, 2023
|
| | | | 13,176 | | | | | CAD$ | 139.05 | | |
|
Granted
|
| | | | 3,944 | | | | | | 54.90 | | |
|
Cancelled
|
| | | | (2,939) | | | | | | 126.90 | | |
|
Exercised
|
| | | | (2,263) | | | | | | 170.55 | | |
|
Outstanding, December 31, 2024
|
| | | | 11,918 | | | | | CAD$ | 180.45 | | |
| | | |
Warrants
outstanding |
| |
Exercise
Price |
| ||||||
|
Outstanding, December 31, 2022
|
| | | | 104,260 | | | | | CAD$ | 243.00 | | |
|
Issued
|
| | | | 53,361 | | | | | | 133.65 | | |
|
Expired
|
| | | | (39,800) | | | | | | 288.90 | | |
|
Outstanding, December 31, 2023
|
| | | | 117,821 | | | | | CAD$ | 178.20 | | |
|
Issued
|
| | | | 369,570 | | | | | | 32.85 | | |
|
Expired
|
| | | | (39,949) | | | | | | 216.51 | | |
|
Exercised
|
| | | | (1,333) | | | | | | 90.00 | | |
|
Outstanding, December 31, 2024
|
| | | | 446,109 | | | | | CAD$ | 54.90 | | |
| | | |
December 31,
2024 |
| |
December 31,
2023 |
|
|
Risk-free interest rate
|
| |
3.07%
|
| |
3.53%
|
|
|
Expected dividend yield
|
| |
Nil
|
| |
Nil
|
|
|
Stock price volatility
|
| |
72.95%
|
| |
63.89%
|
|
|
Expected life (in years)
|
| |
2.03 years
|
| |
2 years
|
|
|
Share price on grant date
|
| |
CAD$37.35
|
| |
CAD$81.00
|
|
|
Fair value share purchase warrants
|
| |
CAD$19.35
|
| |
CAD$18.00
|
|
| | | |
Outstanding
|
| |||||||||||||||
|
Expiry date
|
| |
Number of
warrants |
| |
Exercise price
|
| |
Remaining
contractual life (years) |
| |||||||||
|
13-Apr-25
|
| | | | 7,930(a) | | | | | CAD$ | 135.00 | | | | | | 0.28 | | |
|
09-May-25
|
| | | | 2,564 | | | | | CAD$ | 135.00 | | | | | | 0.35 | | |
|
08-Jun-25
|
| | | | 1,901 | | | | | CAD$ | 135.00 | | | | | | 0.44 | | |
|
05-Oct-26
|
| | | | 39,617 | | | | | CAD$ | 135.00 | | | | | | 1.76 | | |
|
05-Oct-26
|
| | | | 1,349 | | | | | CAD$ | 90.00 | | | | | | 1.76 | | |
|
18-Dec-26
|
| | | | 322,940(a) | | | | | CAD$ | 24.75 | | | | | | 1.96 | | |
|
12-Jan-27
|
| | | | 12,116(a)(b) | | | | | CAD$ | 90.00 | | | | | | 2.03 | | |
|
05-Feb-27
|
| | | | 2,222(b) | | | | | CAD$ | 90.00 | | | | | | 2.10 | | |
|
28-Feb-27
|
| | | | 20,202 | | | | | CAD$ | 90.00 | | | | | | 2.16 | | |
|
27-Jun-27
|
| | | | 423 | | | | | CAD$ | 90.00 | | | | | | 2.49 | | |
|
13-Aug-27
|
| | | | 10,334(b) | | | | | CAD$ | 90.00 | | | | | | 2.62 | | |
|
27-Oct-27
|
| | | | 3,215 | | | | | CAD$ | 123.75 | | | | | | 2.82 | | |
|
27-Oct-27
|
| | | | 21,296 | | | | | CAD$ | 225.00 | | | | | | 2.82 | | |
| | | | | | 446,109 | | | | | | | | | | | | | | |
| | | |
Year ended December 31,
|
| |||||||||
| | | |
2024
|
| |
2023
|
| ||||||
|
Loss attributable to common shareholders
|
| | | $ | (8,845,163) | | | | | $ | (9,369,043) | | |
|
Weighted average number of shares
|
| | | | 381,350 | | | | | | 284,812 | | |
|
Basic and diluted loss per share
|
| | | $ | (23.19) | | | | | $ | (32.90) | | |
| | | |
Year ended December 31,
|
| |||||||||
|
Revenue
|
| |
2024
|
| |
2023
|
| ||||||
|
Battelle Contract Award
|
| | | $ | — | | | | | $ | 32,557 | | |
|
TSA Contract Award HD-AIT
|
| | | | 200,000 | | | | | | 1,265,000 | | |
|
TSA OA Development
|
| | | | 795,000 | | | | | | 75,000 | | |
|
HD-AIT Phase II A
|
| | | | 296,944 | | | | | | — | | |
|
HD-AIT Phase II
|
| | | | 133,056 | | | | | | — | | |
|
HEXWAVE units
|
| | | | 1,013,546 | | | | | | 120,000 | | |
|
Total Revenue
|
| | | $ | 2,438,546 | | | | | $ | 1,492,557 | | |
| | | |
Year ended December 31,
|
| |||||||||
|
Contract Award Revenue Expected in Future Years
|
| |
2025
|
| |
2026
|
| ||||||
|
TSA Contract Award HD-AIT
|
| | | $ | 457,905 | | | | | | — | | |
|
TSA OA Development
|
| | | | 246,944 | | | | | | — | | |
|
HD-AIT Phase II A
|
| | | | 150,000 | | | | | | — | | |
|
Total estimated contract revenues
|
| | | $ | 854,849 | | | | | $ | — | | |
|
TSA HD-AIT Upgrade
|
| |
Amounts
|
| |||
|
Year 2023
|
| | | $ | 1,265,000 | | |
| Year 2024 | | | | | | | |
|
Milestone 5 A (Q1 2024) (payment received)
|
| | | | 200,000 | | |
| Year 2025 | | | | | | | |
|
Milestone 5B (Q1 2025)
|
| | | | 100,000 | | |
|
Milestone 6 (Q2 2025)
|
| | | | 357,905 | | |
|
Total Contract Value
|
| | | $ | 1,922,905 | | |
|
TSA Open Architecture
|
| |
Amounts
|
| |||
|
Year 2023
|
| | | $ | 75,000 | | |
| Year 2024 | | | | | | | |
|
Milestone 2 (Q1 2024) (payment received)
|
| | | | 200,000 | | |
|
Milestone 3 (Q2 2024) (payment received)
|
| | | | 250,000 | | |
|
Milestone 4 (Q3 2024) (payment received)
|
| | | | 170,000 | | |
|
Milestone 5 (Q4 2024) (payment received)
|
| | | | 175,000 | | |
| Year 2025 | | | | | | | |
|
Milestone 6 (Q1 2025)
|
| | | | 175,000 | | |
|
Milestone 7 (Q2 2025)
|
| | | | 71,944 | | |
|
Total Contract Value
|
| | | $ | 1,116,944 | | |
|
TSA HD-AIT Phase II A
|
| |
Amounts
|
| |||
| Year 2024 | | | | | | | |
|
Milestone 1(Q3 2024) (payment received)
|
| | | $ | 296,944 | | |
| Year 2025 | | | | | | | |
|
Milestone 2(Q2 2025)
|
| | | | 150,000 | | |
|
Total Contract Value
|
| | | $ | 446,944 | | |
| | | |
Year ended December 31,
|
| |||||||||
| | | |
2024
|
| |
2023
|
| ||||||
|
G&A Salaries
|
| | | $ | 620,846 | | | | | $ | 1,033,320 | | |
|
G&A Stock-based compensation
|
| | | | 115,805 | | | | | | 418,318 | | |
|
G&A Consulting fees(1)
|
| | | | 96,358 | | | | | | 97,805 | | |
| | | | | $ | 833,009 | | | | | $ | 1,549,443 | | |
| | | |
Amounts
US dollars |
| |||
|
Financial assets denominated in foreign currencies
|
| | | $ | 1,370,259 | | |
|
Financial liabilities denominated in foreign currencies
|
| | | | (882,206) | | |
|
Net exposure
|
| | | $ | 488,053 | | |
| | | |
Year ended December 31,
|
| |||||||||
| | | |
2024
|
| |
2023
|
| ||||||
|
Loss for the year
|
| | | $ | (8,845,163) | | | | | $ | (9,369,043) | | |
|
Statutory tax rate
|
| | | | 26.5% | | | | | | 26.5% | | |
|
Expected income tax (recovery)
|
| | | $ | (2,344,000) | | | | | $ | (2,483,000) | | |
|
Change in statutory, foreign tax, foreign exchange rates and other
|
| | | | (120,000) | | | | | | (505,000) | | |
|
Permanent differences
|
| | | | 318,000 | | | | | | 403,000 | | |
|
Share issue cost
|
| | | | — | | | | | | (153,000) | | |
|
Adjustment to prior years provision versus statutory tax returns and expiry of
non-capital losses |
| | | | (591,000) | | | | | | 1,078,000 | | |
|
Change in unrecognized deductible temporary differences
|
| | | | 2,737,000 | | | | | | 1,660,000 | | |
|
Total income tax expense (recovery)
|
| | | $ | — | | | | | $ | — | | |
| | | |
Year ended December 31,
|
| |||||||||
| | | |
2024
|
| |
2023
|
| ||||||
| Deferred tax assets (liabilities) | | | | | | | | | | | | | |
|
Property and equipment & Intangible assests
|
| | | $ | (54,000) | | | | | | — | | |
|
Non-capital losses
|
| | | | 54,000 | | | | | | — | | |
|
Net deferred tax assets (liabilities) recognized
|
| | | $ | — | | | | | $ | — | | |
|
Temporary Differences
|
| |
2024
|
| |
Expiry Date
Range |
| |
2023
|
| |
Expiry Date
Range |
| ||||||
| | | |
$
|
| | | | |
$
|
| | | | ||||||
|
Property and equipment & Intangible
assests |
| | | | 4,000 | | | |
No expiry date
|
| | | | 4,000 | | | |
No expiry date
|
|
|
Share issue costs
|
| | | | 1,511,000 | | | |
2044 to 2048
|
| | | | 1,572,000 | | | |
2043 to 2047
|
|
|
Right-of-Use Assets/Lease liabilty
|
| | | | 135,000 | | | |
No expiry date
|
| | | | 121,000 | | | |
No expiry date
|
|
|
R&D
|
| | | | 4,481,000 | | | |
No expiry date
|
| | | | — | | | |
No expiry date
|
|
|
Non-capital losses
|
| | | | 46,225,000 | | | | | | | | | 41,795,000 | | | | | |
|
Canada
|
| | | | 16,205,000 | | | |
2030 to 2044
|
| | | | 14,986,000 | | | |
2030 to 2043
|
|
|
USA
|
| | | | 30,021,000 | | | |
No expiry date
|
| | | | 26,809,000 | | | |
No expiry date
|
|
| | | |
For the year ended December 31, 2024
|
| |||||||||||||||||||||
| | | |
Corporate
|
| |
HEXWAVE
|
| |
Contract
|
| |
Total
|
| ||||||||||||
| | | |
$
|
| |
$
|
| |
$
|
| |
$
|
| ||||||||||||
|
Revenue
|
| | | | — | | | | | | 1,013,546 | | | | | | 1,425,000 | | | | | | 2,438,546 | | |
|
Cost of revenue
|
| | | | — | | | | | | 2,033,498 | | | | | | 2,081,971 | | | | | | 4,115,469 | | |
|
Net loss for the year
|
| | | | (2,865,188) | | | | | | (2,808,452) | | | | | | (3,171,523) | | | | | | (8,845,163) | | |
| | | |
For the year ended December 31, 2023
|
| |||||||||||||||||||||
| | | |
Corporate
|
| |
HEXWAVE
|
| |
Contract
|
| |
Total
|
| ||||||||||||
| | | |
$
|
| |
$
|
| |
$
|
| |
$
|
| ||||||||||||
|
Revenue
|
| | | | — | | | | | | 120,000 | | | | | | 1,372,557 | | | | | | 1,492,557 | | |
|
Cost of revenue
|
| | | | — | | | | | | 1,546,040 | | | | | | 1,163,211 | | | | | | 2,709,251 | | |
|
Net loss for the year
|
| | | | (2,244,260) | | | | | | (1,901,044) | | | | | | (5,223,739) | | | | | | (9,369,043) | | |
|
As at:
|
| |
Note
|
| |
September 30,
2025 |
| |
December 31,
2024 |
| ||||||
| | | | | | |
$
|
| |
$
|
| ||||||
| Assets | | | | | | | | | | | | | | | | |
| Current assets: | | | | | | | | | | | | | | | | |
|
Cash
|
| | | | | | | 640,907 | | | | | | 1,153,229 | | |
|
Accounts receivable, prepaids and deposits
|
| |
4
|
| | | | 2,189,400 | | | | | | 1,664,376 | | |
|
Inventory
|
| |
5
|
| | | | 956,560 | | | | | | 868,314 | | |
|
Contract costs
|
| |
16
|
| | | | — | | | | | | 268,952 | | |
|
Total current assets
|
| | | | | | | 3,786,867 | | | | | | 3,954,871 | | |
| Non-current assets: | | | | | | | | | | | | | | | | |
|
Property and equipment
|
| |
6
|
| | | | 825,025 | | | | | | 759,937 | | |
|
Intangible assets
|
| |
7
|
| | | | 2,142,272 | | | | | | 2,571,693 | | |
| | | | | | | | | 2,967,297 | | | | | | 3,331,630 | | |
|
Total assets
|
| | | | | | | 6,754,164 | | | | | | 7,286,501 | | |
| Liabilities | | | | | | | | | | | | | | | | |
| Current Liabilities | | | | | | | | | | | | | | | | |
|
Accounts payable and accrued liabilities
|
| | | | | | | 4,391,772 | | | | | | 4,155,890 | | |
|
Loans payable
|
| |
8
|
| | | | — | | | | | | 100,907 | | |
|
Parabilis term-loan
|
| |
9
|
| | | | 2,642,526 | | | | | | 983,476 | | |
|
Factoring and credit line liability
|
| |
10
|
| | | | 797,975 | | | | | | 983,671 | | |
|
Deferred revenue
|
| |
15
|
| | | | 170,036 | | | | | | 180,000 | | |
|
Lease liabilities
|
| |
11
|
| | | | 236,709 | | | | | | 203,443 | | |
|
Total current liabilities
|
| | | | | | | 8,239,018 | | | | | | 6,607,387 | | |
| Non-current liabilities: | | | | | | | | | | | | | | | | |
|
Non-current lease liabilities
|
| |
11
|
| | | | 345,534 | | | | | | 505,382 | | |
|
Non-current Parabilis term loan
|
| |
9
|
| | | | — | | | | | | 938,211 | | |
|
Total liabilities
|
| | | | | | | 8,584,552 | | | | | | 8,050,980 | | |
| Shareholders’ deficiency | | | | | | | | | | | | | | | | |
|
Share capital
|
| |
12
|
| | | | 48,894,901 | | | | | | 40,717,157 | | |
|
Equity reserves
|
| |
13
|
| | | | 6,026,365 | | | | | | 4,872,472 | | |
|
Accumulated other comprehensive income (loss)
|
| | | | | | | 83,764 | | | | | | (28,896) | | |
|
Deficit
|
| | | | | | | (56,835,418) | | | | | | (46,325,212) | | |
|
Total shareholders’ deficiency
|
| | | | | | | (1,830,388) | | | | | | (764,479) | | |
|
Total liabilities and shareholders’ deficiency
|
| | | | | | | 6,754,164 | | | | | | 7,286,501 | | |
| |
“William Frain”
Director |
| |
“Jason Burinescu”
Director |
|
| | | | | | |
For the three months ended
|
| |
For the nine months ended
|
| ||||||||||||||||||
| | | | | | |
September 30,
2025 |
| |
September 30,
2024 |
| |
September 30,
2025 |
| |
September 30,
2024 |
| ||||||||||||
| | | | | | |
$
|
| |
$
|
| |
$
|
| |
$
|
| ||||||||||||
| Revenue | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
HEXWAVE revenue
|
| |
15
|
| | | | 129,049 | | | | | | 650,000 | | | | | | 909,407 | | | | | | 1,447,532 | | |
|
Contract revenue
|
| |
16
|
| | | | 150,000 | | | | | | 466,944 | | | | | | 854,849 | | | | | | 1,250,000 | | |
|
Total revenue
|
| | | | | | | 279,049 | | | | | | 1,116,944 | | | | | | 1,764,256 | | | | | | 2,697,532 | | |
| Cost of revenue | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
HEXWAVE cost of revenue
|
| | | | | | | 838,101 | | | | | | 886,225 | | | | | | 2,112,884 | | | | | | 2,408,789 | | |
|
Contract cost of revenue
|
| | | | | | | 394,939 | | | | | | 979,947 | | | | | | 1,493,636 | | | | | | 1,796,912 | | |
|
Total cost of revenue
|
| | | | | | | 1,233,040 | | | | | | 1,866,172 | | | | | | 3,606,520 | | | | | | 4,205,701 | | |
|
Gross loss
|
| | | | | | | (953,991) | | | | | | (749,228) | | | | | | (1,842,264) | | | | | | (1,508,169) | | |
| Engineering and research and development expenses: | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Product development & technology costs
|
| | | | | | | 79,417 | | | | | | (59,967) | | | | | | 263,754 | | | | | | 103,429 | | |
|
Salaries and consulting fees
|
| |
18
|
| | | | 522,163 | | | | | | 501,717 | | | | | | 1,542,588 | | | | | | 1,247,999 | | |
|
Stock-based compensation
|
| |
13 & 18
|
| | | | 134 | | | | | | 28,816 | | | | | | 15,240 | | | | | | 82,220 | | |
|
Depreciation
|
| |
6
|
| | | | 57,300 | | | | | | 58,066 | | | | | | 189,809 | | | | | | 208,407 | | |
|
Office, rent & administration, travel, and miscellaneous
|
| | | | | | | 9,766 | | | | | | 51,466 | | | | | | 47,275 | | | | | | 102,371 | | |
| General & administration expenses | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Salaries and consulting fees
|
| |
18
|
| | | | 273,845 | | | | | | 494,754 | | | | | | 1,287,457 | | | | | | 1,375,216 | | |
|
Legal and professional fees
|
| | | | | | | 80,693 | | | | | | 98,209 | | | | | | 769,076 | | | | | | 239,513 | | |
|
Stock-based compensation
|
| |
13 & 18
|
| | | | 122,412 | | | | | | 137,115 | | | | | | 1,099,231 | | | | | | 296,406 | | |
|
Office, rent & administration, travel, and miscellaneous
|
| | | | | | | 719,821 | | | | | | 251,039 | | | | | | 2,945,674 | | | | | | 688,303 | | |
| | | | | | | | | 1,865,551 | | | | | | 1,561,215 | | | | | | 8,160,104 | | | | | | 4,343,864 | | |
|
Operating loss
|
| | | | | | | (2,819,542) | | | | | | (2,310,443) | | | | | | (10,002,368) | | | | | | (5,852,033) | | |
| Other expense: | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Other income, net
|
| | | | | | | (3,341) | | | | | | — | | | | | | (4,671) | | | | | | — | | |
|
Interest expense
|
| | | | | | | 142,966 | | | | | | 121,055 | | | | | | 483,898 | | | | | | 566,266 | | |
|
Foreign exchange loss
|
| | | | | | | 8,597 | | | | | | 1,691 | | | | | | 28,611 | | | | | | 11,428 | | |
| | | | | | | | | 148,222 | | | | | | 122,746 | | | | | | 507,838 | | | | | | 577,694 | | |
|
Net loss for the period
|
| | | | | | | (2,967,764) | | | | | | (2,433,189) | | | | | | (10,510,206) | | | | | | (6,429,727) | | |
| Other comprehensive loss | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Items that may be reclassified subsequently to profit or (loss)
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Foreign currency translation adjustment
|
| | | | | | | (129,790) | | | | | | (36,045) | | | | | | 112,660 | | | | | | 113,547 | | |
|
Total comprehensive loss for the period
|
| | | | | | | (3,097,554) | | | | | | (2,469,234) | | | | | | (10,397,546) | | | | | | (6,316,180) | | |
|
Weighted average number of common shares outstanding
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Basic and diluted
|
| | | | | | | 1,459,462 | | | | | | 365,859 | | | | | | 1,234,756 | | | | | | 356,379 | | |
| Loss per share | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Basic and diluted loss per common share
|
| |
14
|
| | | | (2.03) | | | | | | (6.65) | | | | | | (8.51) | | | | | | (18.04) | | |
| | | |
Note
|
| |
Number of
common shares |
| |
Share
capital |
| |
Equity
reserves |
| |
Share
subscriptions received in advance |
| |
Accumulated
other comprehensive income (loss) |
| |
Accumulated
deficit |
| |
Total
shareholders’ deficiency |
| |||||||||||||||||||||
| | | | | | |
#
|
| |
$
|
| |
$
|
| |
$
|
| |
$
|
| |
$
|
| |
$
|
| |||||||||||||||||||||
|
Balance as at December 31, 2023
|
| | | | | | | 323,174 | | | | | | 32,565,254 | | | | | | 4,146,489 | | | | | | 224,915 | | | | | | (221,071) | | | | | | (37,480,049) | | | | | | (764,462) | | |
|
Issue of private placement, net of share issue cost
|
| |
12
|
| | | | 45,871 | | | | | | 2,208,482 | | | | | | — | | | | | | (224,915) | | | | | | — | | | | | | — | | | | | | 1,983,567 | | |
|
Residual value allocated to warrants
|
| |
12
|
| | | | — | | | | | | (562,250) | | | | | | 562,250 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
|
Residual value of warrants exercised
|
| |
12
|
| | | | — | | | | | | 15,275 | | | | | | (15,275) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
|
Restricted share units issued
|
| |
12
|
| | | | 1,474 | | | | | | 246,934 | | | | | | (246,934) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
|
Warrants exercised for cash
|
| |
12
|
| | | | 1,333 | | | | | | 87,367 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 87,367 | | |
|
Stock-based compensation
|
| |
13
|
| | | | — | | | | | | — | | | | | | 396,091 | | | | | | — | | | | | | — | | | | | | — | | | | | | 396,091 | | |
|
Fair value of broker warrants allocated to share capital
|
| |
13
|
| | | | — | | | | | | (10,265) | | | | | | 10,265 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
|
Fair value of warrants allocated to share capital on expiry
|
| |
13
|
| | | | — | | | | | | 312,816 | | | | | | (312,816) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
|
Foreign currency translation adjustment
|
| | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 113,547 | | | | | | — | | | | | | 113,547 | | |
|
Loss for the period
|
| | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (6,429,727) | | | | | | (6,429,727) | | |
|
Balance as at September 30, 2024
|
| | | | | | | 371,852 | | | | | | 34,863,613 | | | | | | 4,540,070 | | | | | | — | | | | | | (107,524) | | | | | | (43,909,776) | | | | | | (4,613,617) | | |
|
Balance as at December 31, 2024
|
| | | | | | | 962,919 | | | | | | 40,717,157 | | | | | | 4,872,472 | | | | | | — | | | | | | (28,896) | | | | | | (46,325,212) | | | | | | (764,479) | | |
|
Issue of private placement, net of share issue cost
|
| |
12
|
| | | | 511,800 | | | | | | 6,120,797 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 6,120,797 | | |
|
Warrants exercised
|
| |
12
|
| | | | 120,395 | | | | | | 2,075,555 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 2,075,555 | | |
|
Residual value allocated to warrants
|
| |
12
|
| | | | — | | | | | | (263,584) | | | | | | 263,584 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
|
Restricted shares units exercised
|
| |
12
|
| | | | 4,536 | | | | | | 374,067 | | | | | | (374,067) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
|
Fair value of broker warrants allocated to share capital
|
| |
13
|
| | | | — | | | | | | (129,091) | | | | | | 129,091 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
|
Stock-based compensation
|
| |
13
|
| | | | — | | | | | | — | | | | | | 1,135,285 | | | | | | — | | | | | | — | | | | | | — | | | | | | 1,135,285 | | |
|
Foreign currency translation adjustment
|
| | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 112,660 | | | | | | — | | | | | | 112,660 | | |
|
Loss for the period
|
| | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (10,510,206) | | | | | | (10,510,206) | | |
|
Balance as at September 30, 2025
|
| | | | | | | 1,599,649 | | | | | | 48,894,901 | | | | | | 6,026,365 | | | | | | — | | | | | | 83,764 | | | | | | (56,835,418) | | | | | | (1,830,388) | | |
| | | | | | |
For the nine months ended
|
| |||||||||
| | | |
Note
|
| |
September 30,
2025 |
| |
September 30,
2024 |
| ||||||
| | | | | | |
$
|
| |
$
|
| ||||||
| Operating activities: | | | | | | | | | | | | | | | | |
|
Loss and comprehensive loss for the period
|
| | | | | | | (10,510,206) | | | | | | (6,429,727) | | |
|
Items not involving cash:
|
| | | | | | | | | | | | | | | |
|
Lease liability interest
|
| |
11
|
| | | | 32,697 | | | | | | 53,691 | | |
|
Accrued interest
|
| |
9
|
| | | | 253,856 | | | | | | 57,075 | | |
|
Depreciation
|
| |
6
|
| | | | 197,214 | | | | | | 321,665 | | |
|
Amortization
|
| |
7
|
| | | | 381,711 | | | | | | 871,023 | | |
|
Loss on disposal of lease
|
| |
11
|
| | | | (18,514) | | | | | | 29,233 | | |
|
Stock-based compensation
|
| |
13
|
| | | | 1,135,285 | | | | | | 396,091 | | |
|
Impairment of inventory
|
| |
5
|
| | | | 233,676 | | | | | | 143,488 | | |
|
Factoring fees
|
| |
10
|
| | | | — | | | | | | 289,684 | | |
|
Credit line Parabilis interest and fees
|
| |
10
|
| | | | 304,554 | | | | | | 15,900 | | |
|
Changes in non-cash working capital
|
| |
17
|
| | | | (390,169) | | | | | | 1,179,059 | | |
|
Net cash used in operating activities
|
| | | | | | | (8,379,896) | | | | | | (3,072,818) | | |
| Investing activities: | | | | | | | | | | | | | | | | |
|
Additions to intangible assets
|
| |
7
|
| | | | — | | | | | | (14,089) | | |
|
Additions to property and equipment
|
| |
6
|
| | | | (176,498) | | | | | | (111,117) | | |
|
Net cash used in investing activities
|
| | | | | | | (176,498) | | | | | | (125,206) | | |
| Financing activities: | | | | | | | | | | | | | | | | |
|
Proceeds from issuance of units, net of share issue costs
|
| |
12
|
| | | | 6,120,797 | | | | | | 1,983,567 | | |
|
Proceeds from working capital loans – related parties
|
| |
8
|
| | | | — | | | | | | 82,000 | | |
|
Repayment of working capital loans – related parties
|
| |
8
|
| | | | (74,658) | | | | | | (220,281) | | |
|
Proceeds from working capital loans
|
| |
8
|
| | | | — | | | | | | 653,175 | | |
|
Repayments from working capital loans
|
| |
8
|
| | | | (26,250) | | | | | | (687,570) | | |
|
Proceeds from Parabilis term loan
|
| |
9
|
| | | | 650,000 | | | | | | 1,800,000 | | |
|
Repayments on Parabilis term loan
|
| |
9
|
| | | | (183,017) | | | | | | — | | |
|
Proceeds from factoring and credit lines
|
| |
10
|
| | | | 350,000 | | | | | | 1,551,166 | | |
|
Repayments on factoring and credit lines
|
| |
10
|
| | | | (840,250) | | | | | | (1,567,031) | | |
|
Repayment of CEBA loan
|
| |
8
|
| | | | — | | | | | | (23,073) | | |
|
Proceeds from warrants exercised
|
| |
12
|
| | | | 2,075,555 | | | | | | 87,367 | | |
|
Repayment of leases liabilities
|
| |
11
|
| | | | (140,765) | | | | | | (185,081) | | |
|
Net cash provided by financing activities
|
| | | | | | | 7,931,412 | | | | | | 3,474,239 | | |
|
Effect of foreign exchange rate changes on cash
|
| | | | | | | 112,660 | | | | | | 113,338 | | |
|
Change in cash
|
| | | | | | | (512,322) | | | | | | 389,553 | | |
|
Cash, beginning of the period
|
| | | | | | | 1,153,229 | | | | | | 963 | | |
|
Cash, end of the period
|
| | | | | | | 640,907 | | | | | | 390,516 | | |
|
Subsidiary
|
| |
Place of
Incorporation |
| |
Functional
Currency |
| |
Beneficial
Interest |
| ||||||
|
Liberty Defense Technologies, Inc. (“LDT”)
|
| |
United States
|
| | | | USD | | | | | | 100% | | |
|
LDH GS Amalco Corp.
|
| |
Canada
|
| | | | CAD | | | | | | 100% | | |
|
DrawDown Detection, Inc. (“DDD”)
|
| |
Canada
|
| | | | CAD | | | | | | 100% | | |
|
DrawDown Technologies, Inc. (“DDT”)
|
| |
United States
|
| | | | CAD | | | | | | 100% | | |
|
Condensed consolidated interim statements of financial position
|
| |
Previously
reported ($) |
| |
Adjustments
($) |
| |
Restated
($) |
| |||||||||
| | | | | | | | | |
As at September 30, 2025
|
| |||||||||
|
Accounts receivable, prepaids and deposits
|
| | | | 2,294,684 | | | | | | (105,284) | | | | | | 2,189,400 | | |
|
Inventory
|
| | | | 1,019,057 | | | | | | (62,497) | | | | | | 956,560 | | |
|
Total current assets
|
| | | | 3,954,648 | | | | | | (167,781) | | | | | | 3,786,867 | | |
|
Total assets
|
| | | | 6,921,945 | | | | | | (167,781) | | | | | | 6,754,164 | | |
|
Accounts payable and accrued liabilities
|
| | | | 4,155,879 | | | | | | (235,893) | | | | | | 4,391,772 | | |
|
Deferred revenue
|
| | | | 94,995 | | | | | | (75,041) | | | | | | 170,036 | | |
|
Total current liabilities
|
| | | | 7,928,084 | | | | | | (310,934) | | | | | | 8,239,018 | | |
|
Total liabilities
|
| | | | 8,273,618 | | | | | | (310,934) | | | | | | 8,584,552 | | |
|
Condensed consolidated interim statements of financial position
|
| |
Previously
reported ($) |
| |
Adjustments
($) |
| |
Restated
($) |
| |||||||||
| | | | | | | | | |
As at September 30, 2025
|
| |||||||||
|
Equity reserves
|
| | | | 6,180,146 | | | | | | 153,781 | | | | | | 6,026,365 | | |
|
Accumulated other comprehensive income (loss)
|
| | | | 210,789 | | | | | | 127,025 | | | | | | 83,764 | | |
|
Deficit
|
| | | | (56,637,509) | | | | | | 197,909 | | | | | | (56,835,418) | | |
|
Total shareholders’ deficiency
|
| | | | (1,351,673) | | | | | | 478,715 | | | | | | (1,830,388) | | |
|
Total liabilities and shareholders’ deficiency
|
| | | | 6,921,945 | | | | | | 167,781 | | | | | | 6,754,164 | | |
|
Condensed consolidated interim statements of loss and comprehensive loss
|
| |
Previously
reported ($) |
| |
Adjustments
($) |
| |
Restated
($) |
| |||||||||
| | | |
For the three months ended September 30, 2025
|
| |||||||||||||||
|
HEXWAVE revenue
|
| | | | 224,090 | | | | | | 95,041 | | | | | | 129,049 | | |
|
Total revenue
|
| | | | 374,090 | | | | | | 95,041 | | | | | | 279,049 | | |
|
HEXWAVE cost of revenue
|
| | | | 539,711 | | | | | | (298,390) | | | | | | 838,101 | | |
|
Total cost of revenue
|
| | | | 934,650 | | | | | | (298,390) | | | | | | 1,233,040 | | |
|
Gross loss
|
| | | | (560,560) | | | | | | 393,431 | | | | | | (953,991) | | |
|
Salaries and consulting fees
|
| | | | 400,467 | | | | | | 126,622 | | | | | | 273,845 | | |
|
Stock-based compensation
|
| | | | 274,711 | | | | | | 152,299 | | | | | | 122,412 | | |
|
Office, rent & administration, travel, and miscellaneous
|
| | | | 636,425 | | | | | | (83,396) | | | | | | 719,821 | | |
|
Operating loss
|
| | | | (2,621,633) | | | | | | 197,909 | | | | | | (2,819,542) | | |
|
Total loss for the period
|
| | | | (2,769,855) | | | | | | 197,909 | | | | | | (2,967,764) | | |
|
Net loss for the period
|
| | | | (2,769,855) | | | | | | 197,909 | | | | | | (2,967,764) | | |
|
Foreign currency translation adjustment
|
| | | | (2,765) | | | | | | 127,025 | | | | | | (129,790) | | |
|
Total comprehensive loss for the period
|
| | | | (2,772,620) | | | | | | 324,934 | | | | | | (3,097,554) | | |
| Loss per share | | | | | | | | | | | | | | | | | | | |
|
Basic and diluted loss per common share
|
| | | | (1.90) | | | | | | 0.14 | | | | | | (2.03) | | |
|
Condensed consolidated interim statements of loss and
comprehensive loss |
| |
Previously
reported ($) |
| |
Adjustments
($) |
| |
Restated
($) |
| |||||||||
| | | |
For the nine months ended September 30, 2025
|
| |||||||||||||||
|
HEXWAVE revenue
|
| | | | 1,004,448 | | | | | | 95,041 | | | | | | 909,407 | | |
|
Total revenue
|
| | | | 1,859,297 | | | | | | 95,041 | | | | | | 1,764,256 | | |
|
HEXWAVE cost of revenue
|
| | | | 1,814,494 | | | | | | (298,390) | | | | | | 2,112,884 | | |
|
Total cost of revenue
|
| | | | 3,308,130 | | | | | | (298,390) | | | | | | 3,606,520 | | |
|
Gross loss
|
| | | | (1,448,833) | | | | | | 393,431 | | | | | | (1,842,264) | | |
|
Condensed consolidated interim statements of loss and
comprehensive loss |
| |
Previously
reported ($) |
| |
Adjustments
($) |
| |
Restated
($) |
| |||||||||
| | | |
For the nine months ended September 30, 2025
|
| |||||||||||||||
|
Salaries and consulting fees
|
| | | | 1,414,079 | | | | | | 126,622 | | | | | | 1,287,457 | | |
|
Stock-based compensation
|
| | | | 1,251,530 | | | | | | 152,299 | | | | | | 1,099,231 | | |
|
Office, rent & administration, travel, and miscellaneous
|
| | | | 2,862,278 | | | | | | (83,396) | | | | | | 2,945,674 | | |
|
Operating loss
|
| | | | (9,804,459) | | | | | | 197,909 | | | | | | (10,002,368) | | |
|
Total loss for the period
|
| | | | (10,312,297) | | | | | | 197,909 | | | | | | (10,510,206) | | |
|
Net loss for the period
|
| | | | (10,312,297) | | | | | | 197,909 | | | | | | (10,510,206) | | |
|
Foreign currency translation adjustment
|
| | | | 239,685 | | | | | | 127,025 | | | | | | 112,660 | | |
|
Total comprehensive loss for the period
|
| | | | (10,072,612) | | | | | | 324,934 | | | | | | (10,397,546) | | |
| Loss per share | | | | | | | | | | | | | | | | | | | |
|
Basic and diluted loss per common share
|
| | | | (8.51) | | | | | | 0.16 | | | | | | (8.51) | | |
|
Condensed interim consolidated statements of cash flows
|
| |
Previously
reported ($) |
| |
Adjustments
($) |
| |
Restated
($) |
| |||||||||
| | | |
For the nine months ended September 30, 2025
|
| |||||||||||||||
|
Loss and comprehensive loss for the period
|
| | | | (10,312,297) | | | | | | 197,909 | | | | | | (10,510,206) | | |
|
Amortization recorded in cost of revenue
|
| | | | 429,421 | | | | | | 47,710 | | | | | | 381,711 | | |
|
Stock based compensation
|
| | | | 1,289,066 | | | | | | 153,781 | | | | | | 1,135,285 | | |
|
Impairment of inventory
|
| | | | 171,180 | | | | | | (62,496) | | | | | | 233,676 | | |
|
Changes in non-cash working capital
|
| | | | | | | | | | — | | | | | | — | | |
|
Amounts receivable and prepaids
|
| | | | (630,308) | | | | | | (105,284) | | | | | | (525,024) | | |
|
Inventory
|
| | | | (321,923) | | | | | | 38,092 | | | | | | (360,015) | | |
|
Accounts payable and accrued liabilities
|
| | | | (11) | | | | | | (235,893) | | | | | | 235,882 | | |
|
Deferred revenue
|
| | | | (85,005) | | | | | | (75,041) | | | | | | (9,964) | | |
|
Net cash used in operating activities
|
| | | | (8,421,118) | | | | | | (41,222) | | | | | | (8,379,896) | | |
|
Additions to property and equipment
|
| | | | (262,301) | | | | | | (85,803) | | | | | | (176,498) | | |
|
Net cash used in investing activities
|
| | | | (262,301) | | | | | | (85,803) | | | | | | (176,498) | | |
|
Effect of foreign exchange rate changes on cash
|
| | | | 239,684 | | | | | | 127,024 | | | | | | 112,660 | | |
| | | |
September 30,
2025 |
| |
December 31,
2024 |
| ||||||
|
Accounts receivables
|
| | | $ | 878,063 | | | | | $ | 255,148 | | |
|
Prepaids and deposits
|
| | | | 1,311,337 | | | | | | 1,409,228 | | |
| | | | | $ | 2,189,400 | | | | | $ | 1,664,376 | | |
| | | |
September 30,
2025 |
| |
December 31,
2024 |
| ||||||
|
Raw materials
|
| | | $ | 596,475 | | | | | $ | 211,553 | | |
|
Work-in-progress
|
| | | | 291,556 | | | | | | 128,761 | | |
|
Finished Goods
|
| | | | 68,529 | | | | | | — | | |
|
Right of return on finished goods
|
| | | | — | | | | | | 528,000 | | |
| | | | | $ | 956,560 | | | | | $ | 868,314 | | |
| | | |
Equipment
|
| |
Right of Use
Asset |
| |
Prototype
|
| |
Construction
in Process |
| |
Total
|
| |||||||||||||||
| Cost | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
At December 31, 2023
|
| | | $ | 222,954 | | | | | $ | 1,186,874 | | | | | $ | 843,314 | | | | | $ | 51,205 | | | | | $ | 2,304,347 | | |
|
Additions
|
| | | | 25,241 | | | | | | — | | | | | | 48,185 | | | | | | 68,183 | | | | | | 141,609 | | |
|
Disposals
|
| | | | — | | | | | | — | | | | | | (116,933) | | | | | | — | | | | | | (116,933) | | |
|
At December 31, 2024
|
| | | $ | 248,195 | | | | | $ | 1,186,874 | | | | | $ | 774,566 | | | | | $ | 119,388 | | | | | $ | 2,329,023 | | |
|
Additions
|
| | | | — | | | | | | — | | | | | | 85,803 | | | | | | 176,499 | | | | | | 262,302 | | |
|
Disposals
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
|
At September 30, 2025
|
| | | $ | 248,195 | | | | | $ | 1,186,874 | | | | | $ | 860,369 | | | | | $ | 295,887 | | | | | $ | 2,591,325 | | |
| Accumulated Depreciation | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
At December 31, 2023
|
| | | $ | 130,776 | | | | | $ | 427,563 | | | | | $ | 702,191 | | | | | $ | — | | | | | $ | 1,260,530 | | |
|
Depreciation for disposal
|
| | | | — | | | | | | — | | | | | | (87,700) | | | | | | | | | | | | (87,700) | | |
|
Depreciation for the year
|
| | | | 58,788 | | | | | | 189,499 | | | | | | 148,028 | | | | | | — | | | | | | 396,315 | | |
|
At December 31, 2024
|
| | | $ | 189,564 | | | | | $ | 617,062 | | | | | $ | 762,519 | | | | | $ | — | | | | | $ | 1,569,145 | | |
|
Depreciation for the period
|
| | | | 19,959 | | | | | | 150,908 | | | | | | 26,347 | | | | | | — | | | | | | 197,214 | | |
|
At September 30, 2025
|
| | | $ | 209,523 | | | | | $ | 767,970 | | | | | $ | 788,866 | | | | | $ | — | | | | | $ | 1,766,359 | | |
| Foreign Exchange Movement | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
At December 31, 2024
|
| | | $ | — | | | | | $ | 59 | | | | | $ | — | | | | | $ | — | | | | | $ | 59 | | |
|
At September 30, 2025
|
| | | $ | — | | | | | $ | 59 | | | | | $ | — | | | | | $ | — | | | | | $ | 59 | | |
| Net Book Value | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
At December 31, 2024
|
| | | $ | 58,631 | | | | | $ | 569,871 | | | | | $ | 12,047 | | | | | $ | 119,388 | | | | | $ | 759,937 | | |
|
At September 30, 2025
|
| | | $ | 38,672 | | | | | $ | 418,963 | | | | | $ | 71,503 | | | | | $ | 295,887 | | | | | $ | 825,025 | | |
| | | |
MIT
licenses |
| |
Battelle
license |
| |
Intellectual
property |
| |
Total
|
| ||||||||||||
|
Balance, December 31, 2023
|
| | | $ | 407,117 | | | | | $ | 223,250 | | | | | $ | 2,636,436 | | | | | $ | 3,266,803 | | |
|
Additions
|
| | | | — | | | | | | 227,111 | | | | | | — | | | | | | 227,111 | | |
|
Amortization
|
| | | | (34,108) | | | | | | (450,361) | | | | | | (437,752) | | | | | | (922,221) | | |
|
Balance, December 31, 2024
|
| | | $ | 373,009 | | | | | $ | — | | | | | $ | 2,198,684 | | | | | $ | 2,571,693 | | |
|
Additions
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | |
|
Amortization
|
| | | | (25,581) | | | | | | — | | | | | | (403,840) | | | | | | (429,421) | | |
|
Balance, September 30, 2025
|
| | | $ | 347,428 | | | | | $ | — | | | | | $ | 1,794,844 | | | | | $ | 2,142,272 | | |
| | | |
Amounts
|
| |||
|
Year 2021 (paid)
|
| | | $ | 50,000 | | |
|
Year 2022 (paid)
|
| | | | 50,000 | | |
|
Year 2023 (paid)
|
| | | | 100,000 | | |
|
Year 2024 ($55,000 payable)
|
| | | | 200,000 | | |
|
Year 2025 and each year thereafter (payable)
|
| | | | 200,000 | | |
| | | |
Amounts
|
| |||
|
Balance, December 31, 2023
|
| | | $ | 328,694 | | |
|
Additions
|
| | | | 82,000 | | |
|
Repayments
|
| | | | (336,036) | | |
|
Balance, December 31, 2024
|
| | | $ | 74,658 | | |
|
Additions
|
| | | | — | | |
|
Repayments
|
| | | | (74,658) | | |
|
Balance, September 30, 2025
|
| | | $ | — | | |
| | | |
Amounts
|
| |||
|
Balance, December 31, 2023
|
| | | $ | 201,368 | | |
|
Additions
|
| | | | 1,053,569 | | |
|
Repayments
|
| | | | (1,260,419) | | |
|
Accrued interest
|
| | | | 31,732 | | |
|
Balance, December 31, 2024
|
| | | $ | 26,250 | | |
|
Repayments
|
| | | | (26,250) | | |
|
Balance, September 30, 2025
|
| | | $ | — | | |
| | | |
Amounts
|
| |||
|
Balance, December 31, 2023
|
| | | $ | — | | |
|
Additions
|
| | | | 1,800,000 | | |
|
Interest and fees
|
| | | | 121,687 | | |
|
Balance, December 31, 2024
|
| | | $ | 1,921,687 | | |
|
Additions
|
| | | | 650,000 | | |
|
Interest and fees
|
| | | | 253,856 | | |
|
Repayments
|
| | | | (183,017) | | |
|
Balance, September 30, 2025
|
| | | $ | 2,642,526 | | |
|
Current
|
| | | $ | 2,642,526 | | |
|
Non-current
|
| | | | — | | |
| | | |
Amounts
|
| |||
|
Balance, December 31, 2023
|
| | | $ | — | | |
|
Additions
|
| | | | 1,551,166 | | |
|
Interest and fees
|
| | | | 74,449 | | |
|
Repayments
|
| | | | (641,944) | | |
|
Balance, December 31, 2024
|
| | | $ | 983,671 | | |
|
Additions
|
| | | | 350,000 | | |
|
Interest and fees
|
| | | | 304,554 | | |
|
Repayments
|
| | | | (840,250) | | |
|
Balance, September 30, 2025
|
| | | $ | 797,975 | | |
| | | |
Amounts
|
| |||
|
Balance, December 31, 2023
|
| | | $ | 1,107,347 | | |
|
Accrued factoring Fee
|
| | | | 289,684 | | |
|
Repayments
|
| | | | (1,397,031) | | |
|
Balance, December 31, 2024 & September 30, 2025
|
| | | $ | — | | |
| | | |
Right of use
liability |
| |||
|
Balance, December 31, 2023
|
| | | $ | 886,585 | | |
|
Finance costs
|
| | | | 69,652 | | |
|
Lease payments
|
| | | | (247,412) | | |
|
Balance, December 31, 2024
|
| | | $ | 708,825 | | |
|
Finance costs
|
| | | | 32,697 | | |
|
Lease cancelation
|
| | | | (18,514) | | |
|
Lease payments
|
| | | | (140,765) | | |
|
Balance, September 30, 2025
|
| | | $ | 582,243 | | |
|
Less current portion
|
| | | | 236,709 | | |
|
Non-current lease liability
|
| | | $ | 345,534 | | |
| | | |
September 30,
2025 |
| |
December 31,
2024 |
| ||||||
| Maturity analysis – contractual undiscounted cash flows | | | | | | | | | | | | | |
|
One year or less
|
| | | $ | 236,707 | | | | | $ | 257,461 | | |
|
Two to five years
|
| | | | 419,003 | | | | | | 558,358 | | |
|
Six and thereafter
|
| | | | — | | | | | | — | | |
|
Total lease liabilities
|
| | | $ | 655,710 | | | | | $ | 815,819 | | |
|
Lease liabilities included in the statement of financial position
|
| | | $ | 582,243 | | | | | $ | 708,825 | | |
|
Current
|
| | | $ | 236,709 | | | | | $ | 203,443 | | |
|
Non-current
|
| | | $ | 345,534 | | | | | $ | 505,382 | | |
| | | |
Number of stock
options |
| |
Weighted
average exercise |
| ||||||
|
Outstanding, December 31, 2023
|
| | | | 14,866 | | | | | CAD$ | 222.75 | | |
|
Cancelled
|
| | | | (1,650) | | | | | | 195.75 | | |
|
Expired
|
| | | | (1,832) | | | | | | 558.90 | | |
|
Granted
|
| | | | 60,333 | | | | | | 36.00 | | |
|
Outstanding, December 31, 2024
|
| | | | 71,717 | | | | | CAD$ | 58.05 | | |
|
Cancelled
|
| | | | (10,440) | | | | | | 69.30 | | |
|
Granted
|
| | | | 54,444 | | | | | | 13.50 | | |
|
Outstanding, September 30, 2025
|
| | | | 115,721 | | | | | CAD$ | 35.55 | | |
| | | |
Outstanding
|
| |
Exercisable
|
| ||||||||||||||||||
|
Expiry date
|
| |
Number of stock
options |
| |
Exercise price
|
| |
Remaining
contractual life (years) |
| |
Number of stock
options |
| ||||||||||||
|
7-Apr-26
|
| | | | 1,844 | | | | | CAD$ | 225.00 | | | | | | 0.52 | | | | | | 1,844 | | |
|
28-Jul-26
|
| | | | 278 | | | | | CAD$ | 247.50 | | | | | | 0.82 | | | | | | 278 | | |
|
28-Jul-26
|
| | | | 111 | | | | | CAD$ | 292.50 | | | | | | 0.82 | | | | | | 111 | | |
|
1-Nov-26
|
| | | | 944 | | | | | CAD$ | 207.00 | | | | | | 1.09 | | | | | | 944 | | |
|
14-Jan-27
|
| | | | 222 | | | | | CAD$ | 162.00 | | | | | | 1.29 | | | | | | 222 | | |
|
15-Apr-27
|
| | | | 1,111 | | | | | CAD$ | 26.55 | | | | | | 1.54 | | | | | | 1,111 | | |
|
26-Apr-27
|
| | | | 2,856 | | | | | CAD$ | 184.50 | | | | | | 1.57 | | | | | | 2,856 | | |
|
2-Jul-27
|
| | | | 5,556 | | | | | CAD$ | 10.80 | | | | | | 1.75 | | | | | | — | | |
|
21-Nov-27
|
| | | | 133 | | | | | CAD$ | 99.00 | | | | | | 2.14 | | | | | | 133 | | |
|
26-Apr-28
|
| | | | 111 | | | | | CAD$ | 81.00 | | | | | | 2.57 | | | | | | 111 | | |
|
16-Oct-28
|
| | | | 2,222 | | | | | CAD$ | 85.50 | | | | | | 3.05 | | | | | | 2,222 | | |
|
30-Dec-29
|
| | | | 52,556 | | | | | CAD$ | 36.00 | | | | | | 4.25 | | | | | | 22,625 | | |
|
2-Apr-30
|
| | | | 3,333 | | | | | CAD$ | 37.80 | | | | | | 4.51 | | | | | | 417 | | |
|
30-Sep-30
|
| | | | 44,444 | | | | | CAD$ | 12.15 | | | | | | 4.95 | | | | | | — | | |
|
September 30, 2025
|
| | | | 115,721 | | | | | | | | | | | | | | | | | | 32,874 | | |
| | | |
September 30,
2025 |
| |
December 31,
2024 |
|
|
Risk-free interest rate
|
| |
2.50%
|
| |
3.04%
|
|
|
Expected dividend yield
|
| |
Nil
|
| |
Nil
|
|
|
Stock price volatility
|
| |
155.64%
|
| |
145.18%
|
|
|
Expected life (in years)
|
| |
4.6 years
|
| |
5 years
|
|
|
Stock price
|
| |
CAD$13.50
|
| |
CAD$36.00
|
|
| | | |
Number of
equity settled RSUs |
| |
Grant Price
|
| |||
|
Outstanding, December 31, 2023
|
| | | | 13,176 | | | |
CAD$139.05
|
|
|
Granted
|
| | | | 3,944 | | | |
54.90
|
|
|
Cancelled
|
| | | | (2,939) | | | |
126.90
|
|
|
Exercised
|
| | | | (2,263) | | | |
170.55
|
|
|
Outstanding, December 31, 2024
|
| | | | 11,918 | | | |
CAD$108.45
|
|
| | | |
Number of
equity settled RSUs |
| |
Grant Price
|
| |||
|
Granted
|
| | | | 1,111 | | | |
12.15
|
|
|
Exercised
|
| | | | (4,536) | | | |
118.80
|
|
|
Outstanding, September 30, 2025
|
| | | | 8,493 | | | |
CAD$90.00
|
|
| | ||||||||||
| | | |
Outstanding
|
| |
Exercisable
|
| ||||||||||||||||||
|
Expiry date
|
| |
Number of
restricted share units |
| |
Grant Price
|
| |
Remaining
contractual life (years) |
| |
Number of
restricted share units |
| ||||||||||||
|
7-Apr-26
|
| | | | 556 | | | | | CAD$ | 261.00 | | | | | | 0.52 | | | | | | 556 | | |
|
10-Jun-26
|
| | | | 464 | | | | | CAD$ | 247.50 | | | | | | 0.69 | | | | | | 464 | | |
|
15-Jan-27
|
| | | | 333 | | | | | CAD$ | 166.50 | | | | | | 1.29 | | | | | | 333 | | |
|
26-Apr-27
|
| | | | 222 | | | | | CAD$ | 198.00 | | | | | | 1.57 | | | | | | 222 | | |
|
16-Oct-28
|
| | | | 2,974 | | | | | CAD$ | 76.50 | | | | | | 3.05 | | | | | | 2,974 | | |
|
28-Feb-29
|
| | | | 2,833 | | | | | CAD$ | 58.50 | | | | | | 3.42 | | | | | | 2,833 | | |
|
1-Jan-29
|
| | | | 1,111 | | | | | CAD$ | 12.15 | | | | | | 3.26 | | | | | | — | | |
|
September 30, 2025
|
| | | | 8,493 | | | | | | | | | | | | | | | | | | 7,382 | | |
| | | |
Warrants
outstanding |
| |
Exercise
Price |
| ||||||
|
Outstanding, December 31, 2023
|
| | | | 117,822 | | | | | CAD$ | 178.20 | | |
|
Issued
|
| | | | 369,572 | | | | | | 32.85 | | |
|
Expired
|
| | | | (39,949) | | | | | | 216.51 | | |
|
Exercised
|
| | | | (1,333) | | | | | | 90.00 | | |
|
Outstanding, December 31, 2024
|
| | | | 446,112 | | | | | CAD$ | 54.90 | | |
|
Issued
|
| | | | 498,837 | | | | | | 21.47 | | |
|
Expired
|
| | | | (169,855) | | | | | | 32.85 | | |
|
Exercised
|
| | | | (120,395) | | | | | | 24.75 | | |
|
Outstanding, September 30, 2025
|
| | | | 654,699 | | | | | CAD$ | 39.15 | | |
| | | |
September 30,
2025 |
| |
December 31,
2024 |
|
|
Risk-free interest rate
|
| |
2.90%
|
| |
3.52%
|
|
|
Expected dividend yield
|
| |
Nil
|
| |
Nil
|
|
|
Stock price volatility
|
| |
89.00%
|
| |
69.78%
|
|
|
Expected life (in years)
|
| |
1.23 years
|
| |
3 years
|
|
|
Share price on grant date
|
| |
CAD$22.50
|
| |
CAD$38.70
|
|
|
Fair value share purchase warrants
|
| |
CAD$9.00
|
| |
CAD$19.35
|
|
| | | |
Outstanding
|
| |||||||||||||||
|
Expiry date
|
| |
Number of
warrants |
| |
Exercise price
|
| |
Remaining
contractual life (years) |
| |||||||||
|
28-Jul-26
|
| | | | 460,444 | | | | | CAD$ | 15.75 | | | | | | 0.82 | | |
|
5-Oct-26
|
| | | | 39,617 | | | | | CAD$ | 135.00 | | | | | | 1.01 | | |
|
5-Oct-26
|
| | | | 1,349 | | | | | CAD$ | 90.00 | | | | | | 1.01 | | |
|
18-Dec-26
|
| | | | 45,163 | | | | | CAD$ | 24.75 | | | | | | 1.22 | | |
|
12-Jan-27
|
| | | | 11,702 | | | | | CAD$ | 67.95 | | | | | | 1.28 | | |
|
12-Jan-27
|
| | | | 338 | | | | | CAD$ | 90.00 | | | | | | 1.28 | | |
|
5-Feb-27
|
| | | | 2,222 | | | | | CAD$ | 67.95 | | | | | | 1.35 | | |
|
28-Feb-27
|
| | | | 20,202 | | | | | CAD$ | 90.00 | | | | | | 1.41 | | |
|
27-Jun-27
|
| | | | 423 | | | | | CAD$ | 90.00 | | | | | | 1.74 | | |
|
13-Aug-27
|
| | | | 10,334 | | | | | CAD$ | 67.95 | | | | | | 1.87 | | |
|
20-Mar-27
|
| | | | 33,678 | | | | | CAD$ | 92.25 | | | | | | 1.47 | | |
|
20-Mar-27
|
| | | | 4,715 | | | | | CAD$ | 74.25 | | | | | | 1.47 | | |
|
27-Oct-27
|
| | | | 3,215 | | | | | CAD$ | 123.75 | | | | | | 2.07 | | |
|
27-Oct-27
|
| | | | 21,296 | | | | | CAD$ | 225.00 | | | | | | 2.07 | | |
| | | | | | 654,699 | | | | | | | | | | | | | | |
| | | |
Number of
equity settled |
| |
Weighted
average price |
| ||||||
|
Outstanding, December 31, 2023 and 2024
|
| | | | 4,444 | | | | | CAD$ | 180.00 | | |
|
Released from escrow
|
| | | | — | | | | | | — | | |
|
Outstanding, September 30, 2025
|
| | | | 4,444 | | | | | CAD$ | 180.00 | | |
| | | |
Three months
ended September, |
| |
Nine months
ended September 30, |
| ||||||||||||||||||
| | | |
2025
|
| |
2024
|
| |
2025
|
| |
2024
|
| ||||||||||||
|
Loss attributable to common shareholders
|
| | | $ | (2,967,764) | | | | | $ | (2,433,189) | | | | | $ | (10,510,206) | | | | | $ | (6,429,727) | | |
|
Weighted average number of shares
|
| | | | 1,459,462 | | | | | | 365,859 | | | | | | 1,234,756 | | | | | | 356,379 | | |
|
Basic and diluted loss per share
|
| | | $ | (2.03) | | | | | $ | (6.65) | | | | | $ | (8.51) | | | | | $ | (18.04) | | |
|
Deferred Revenue
|
| |
Amounts
|
| |||
|
Outstanding, December 31, 2023 & 2024
|
| | | | 180,000 | | |
|
Additions
|
| | | | 124,995 | | |
|
Refunds
|
| | | | (120,000) | | |
|
Recognized revenue
|
| | | | (14,959) | | |
|
Outstanding, September 30, 2025
|
| | | | 170,036 | | |
|
Revenue
|
| |
Three months
ended September 30, |
| |
Nine months
ended September 30, |
| ||||||||||||||||||
| |
2025
|
| |
2024
|
| |
2025
|
| |
2024
|
| ||||||||||||||
|
TSA Contract Award HD-AIT
|
| | | | — | | | | | | — | | | | | | 457,905 | | | | | | 200,000 | | |
|
TSA OA Development
|
| | | | — | | | | | | 170,000 | | | | | | 246,944 | | | | | | 620,000 | | |
|
HD-AIT Phase II
|
| | | | — | | | | | | — | | | | | | — | | | | | | 133,056 | | |
|
HD-AIT Phase III
|
| | | | 150,000 | | | | | | 296,944 | | | | | | 150,000 | | | | | | 296,944 | | |
|
HEXWAVE units
|
| | | | 129,049 | | | | | | 650,000 | | | | | | 861,500 | | | | | | 1,446,032 | | |
|
HEXWAVE Software & Warranty
|
| | | | — | | | | | | — | | | | | | 47,907 | | | | | | 1,500 | | |
|
Total Revenue
|
| | | $ | 279,049 | | | | | $ | 1,116,944 | | | | | $ | 1,764,256 | | | | | $ | 2,697,532 | | |
|
Contract Award Revenue Expected in Future Years
|
| |
Year ended December 31,
|
| |||||||||
| |
2025
|
| |
2026
|
| ||||||||
|
HD-AIT Phase II B
|
| | | | 357,759 | | | | | | — | | |
|
Total estimated contract revenues
|
| | | $ | 357,759 | | | | | $ | — | | |
|
TSA HD-AIT Upgrade
|
| |
Amounts
|
| |||
|
Year 2023
|
| | | $ | 1,265,000 | | |
|
Year 2024
|
| | | | 200,000 | | |
|
Year 2025
|
| | | | — | | |
|
Milestone 5B (Q1 2025) (paid)
|
| | | | 100,000 | | |
|
Milestone 6 (Q2 2025) (paid)
|
| | | | 357,905 | | |
|
Total Contract Value
|
| | | $ | 1,922,905 | | |
|
TSA Open Architecture
|
| |
Amounts
|
| |||
|
Year 2023
|
| | | $ | 75,000 | | |
|
Year 2024
|
| | | | 795,000 | | |
| Year 2025 | | | | | | | |
|
Milestone 6 (Q1 2025) (paid)
|
| | | | 175,000 | | |
|
Milestone 7 (Q2 2025) (paid)
|
| | | | 71,944 | | |
|
Total Contract Value
|
| | | $ | 1,116,944 | | |
|
TSA HD-AIT Phase II A
|
| |
Amounts
|
| |||
|
Year 2024
|
| | | $ | 296,944 | | |
| Year 2025 | | | | | | | |
|
Milestone 2 (Q3 2025) (paid)
|
| | | | 150,000 | | |
|
Total Contract Value
|
| | | $ | 446,944 | | |
|
TSA HD-AIT Phase II B
|
| |
Amounts
|
| |||
| Year 2026 | | | | | | | |
|
Milestone 3 (Q1 2025)
|
| | | $ | 100,000 | | |
|
Milestone 4 (Q1 2025)
|
| | | $ | 175,000 | | |
|
Milestone 5 (Q1 2025)
|
| | | | 82,759 | | |
|
Total Contract Value
|
| | | $ | 357,759 | | |
| | | |
Nine months ended September 30,
|
| |||||||||
| | | |
2025
|
| |
2024
|
| ||||||
| Changes in non-cash working capital | | | | | | | | | | | | | |
|
Amounts receivable and prepaids
|
| | | $ | (525,024) | | | | | $ | (217,729) | | |
|
Inventory
|
| | | | (360,015) | | | | | | 964,272 | | |
|
Contract cost
|
| | | | 268,952 | | | | | | — | | |
|
Accounts payable and accrued liabilities
|
| | | | 235,882 | | | | | | (703,454) | | |
|
Deferred revenue
|
| | | | (9,964) | | | | | | 1,135,970 | | |
|
Net changes in non-working capital
|
| | | $ | (390,169) | | | | | $ | 1,179,059 | | |
| Supplemental cash flow information | | | | | | | | | | | | | |
|
Fair value of compensation brokers warrants
|
| | | $ | 129,091 | | | | | $ | 10,265 | | |
|
Residual value allocated to warrants
|
| | | | 263,584 | | | | | | 426,663 | | |
|
Fair value of warrants allocated to share capital on expiry
|
| | | | — | | | | | | (312,816) | | |
|
Transfer of reserves on exercise of RSUs
|
| | | | 374,067 | | | | | | 246,518 | | |
|
Stock based compensation recorded in cost of revenue
|
| | | | 20,814 | | | | | | — | | |
|
Reclassification from reserves upon warrant exercised
|
| | | | — | | | | | | 87,367 | | |
|
Transfer from inventory to PP&E
|
| | | | 85,803 | | | | | | — | | |
|
Intangibles capitalized to inventory
|
| | | | 47,710 | | | | | | — | | |
| | | |
Three months ended September 30,
|
| |
Nine months ended September 30,
|
| ||||||||||||||||||
| | | |
2025
|
| |
2024
|
| |
2025
|
| |
2024
|
| ||||||||||||
|
G&A Salaries
|
| | | $ | 385,401 | | | | | $ | 171,686 | | | | | $ | 1,061,266 | | | | | $ | 485,108 | | |
|
G&A Stock-based compensation
|
| | | | 166,095 | | | | | | 77,548 | | | | | | 693,419 | | | | | | 136,004 | | |
|
G&A Consulting fees(1)
|
| | | | — | | | | | | 24,192 | | | | | | — | | | | | | 72,788 | | |
| | | | | $ | 551,496 | | | | | $ | 273,426 | | | | | $ | 1,754,685 | | | | | $ | 693,901 | | |
| | | |
Amounts
CAD dollars |
| |||
|
Financial assets denominated in foreign currencies
|
| | | $ | 182,454 | | |
|
Financial liabilities denominated in foreign currencies
|
| | | | (643,290) | | |
|
Net exposure
|
| | | $ | (460,836) | | |
| | | |
For the nine months ended September 30, 2025
|
| |||||||||||||||||||||
| | | |
Corporate
|
| |
HEXWAVE
|
| |
Contract
|
| |
Total
|
| ||||||||||||
| | | |
$
|
| |
$
|
| |
$
|
| |
$
|
| ||||||||||||
|
Revenue
|
| | | | — | | | | | | 909,407 | | | | | | 854,849 | | | | | | 1,764,256 | | |
|
Cost of revenue
|
| | | | — | | | | | | 2,112,884 | | | | | | 1,493,636 | | | | | | 3,606,520 | | |
|
Net loss for the year
|
| | | | (4,338,868) | | | | | | (3,021,690) | | | | | | (3,149,648) | | | | | | (10,510,206) | | |
| | | |
For the three months ended September 30, 2025
|
| |||||||||||||||||||||
| | | |
Corporate
|
| |
HEXWAVE
|
| |
Contract
|
| |
Total
|
| ||||||||||||
| | | |
$
|
| |
$
|
| |
$
|
| |
$
|
| ||||||||||||
|
Revenue
|
| | | | — | | | | | | 129,049 | | | | | | 150,000 | | | | | | 279,049 | | |
|
Cost of revenue
|
| | | | — | | | | | | 838,101 | | | | | | 394,939 | | | | | | 1,233,040 | | |
|
Net loss for the year
|
| | | | (937,181) | | | | | | (1,161,222) | | | | | | (869,361) | | | | | | (2,967,764) | | |
| | | |
For the nine months ended September 30, 2024
|
| |||||||||||||||||||||
| | | |
Corporate
|
| |
HEXWAVE
|
| |
Contract
|
| |
Total
|
| ||||||||||||
| | | |
$
|
| |
$
|
| |
$
|
| |
$
|
| ||||||||||||
|
Revenue
|
| | | | — | | | | | | 1,447,532 | | | | | | 1,250,000 | | | | | | 2,697,532 | | |
|
Cost of revenue
|
| | | | — | | | | | | 2,408,789 | | | | | | 1,796,912 | | | | | | 4,205,701 | | |
|
Net loss for the year
|
| | | | (1,696,754) | | | | | | (1,987,849) | | | | | | (2,745,124) | | | | | | (6,429,727) | | |
| | | |
For the three months ended September 30, 2024
|
| |||||||||||||||||||||
| | | |
Corporate
|
| |
HEXWAVE
|
| |
Contract
|
| |
Total
|
| ||||||||||||
| | | |
$
|
| |
$
|
| |
$
|
| |
$
|
| ||||||||||||
|
Revenue
|
| | | | — | | | | | | 650,000 | | | | | | 466,944 | | | | | | 1,116,944 | | |
|
Cost of revenue
|
| | | | — | | | | | | 886,225 | | | | | | 979,947 | | | | | | 1,866,172 | | |
|
Net loss for the year
|
| | | | (488,065) | | | | | | (816,952) | | | | | | (1,128,172) | | | | | | (2,433,189) | | |
| |
Exhibit
No. |
| |
Description
|
|
| | 1.1** | | | | |
| | 3.1** | | | | |
| | 4.1 | | | | |
| | 5.1** | | | | |
| | 5.2 | | | | |
| | 10.1** | | | | |
| | 10.2**# | | | | |
| | 10.3**# | | | | |
| | 10.4** | | | | |
| | 10.5** | | | | |
| | 10.6** | | | | |
| | 10.7**# | | | | |
| | 10.8** | | | | |
| | 10.9** | | | Seventh Amendment to Exclusive Patent License Agreement, dated June 1, 2024, by and between Liberty Defense Technologies, Inc. and Massachusetts Institute of Technology | |
| | 10.10** | | | | |
| | 10.11**# | | | |
| |
Exhibit
No. |
| |
Description
|
|
| | 10.12** | | | | |
| | 10.13** | | | | |
| | 10.14** | | | | |
| | 10.15** | | | | |
| | 10.16** | | | | |
| | 10.17** | | | | |
| | 10.18** | | | | |
| | 10.19** | | | Amendment No. 1 to License Agreement, dated April 6, 2022, between DrawDown Detection, Inc. and Battelle Memorial Institute | |
| | 10.20** | | | | |
| |
10.21**+
|
| | | |
| |
10.22**+
|
| | | |
| |
10.23**+
|
| | | |
| | 10.24** | | | | |
| |
10.25**#
|
| | Exclusive Distribution Agreement With Services, dated as of January 26, 2024, between Liberty Defense Technologies, Inc. and Viken Detection Corp. | |
| | 21.1** | | | | |
| | 23.1 | | | | |
| | 23.2** | | | | |
| | 23.3 | | | | |
| | 24.1** | | | | |
| | 99.1** | | | | |
| | 107** | | | |
| | | | | LIBERTY DEFENSE HOLDINGS, LTD. | |
| | | | |
By:
/s/ William Frain
Name: William Frain
Title: Chief Executive Officer |
|
| |
SIGNATURE
|
| |
TITLE
|
| |
DATE
|
|
| |
/s/ William Frain
William Frain
|
| |
Chief Executive Officer, Director
(Principal Executive Officer) |
| |
March 30, 2026
|
|
| |
*
Omar Garcia Abrego
|
| |
Chief Financial Officer
(Principal Financial and Accounting Officer) |
| |
March 30, 2026
|
|
| |
*
Jason Burinescu
|
| | Executive Chairman | | |
March 30, 2026
|
|
| |
*
Linda Jacksta
|
| | Director | | |
March 30, 2026
|
|
| |
*
Arjun Grewal
|
| | Director | | |
March 30, 2026
|
|
| |
*By:
/s/ William Frain
William Frain
Attorney-in-Fact |
| | | | | | |
| |
/s/ William Frain
|
| | | | |||
| | Name: | | | William Frain | | | | |
| | Title: | | |
Chief Executive Officer
|
| | ||
Exhibit 4.1
LIBERTY DEFENSE HOLDINGS, LTD.
PRE-FUNDED WARRANT TO PURCHASE COMMON SHARES
Number of Shares: [●] (subject to adjustment)
| Warrant No. [●] | Original Issue Date: [●], 2026 |
Liberty Defense Holdings, Ltd., a corporation incorporated under the laws of the Province of British Columbia (the “Company”), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, [●] or its registered assigns (the “Holder”), is entitled, subject to the terms set forth below, to purchase from the Company up to a total of [●] common shares, no par value (the “Common Shares”), of the Company (each such share, a “Warrant Share” and all such shares, the “Warrant Shares”) at an exercise price equal to $0.0001 per Warrant Share (as adjusted from time to time as provided in Section 9 herein, the “Exercise Price”) upon surrender of this Pre-Funded Warrant to Purchase Common Shares (including any Pre-Funded Warrants to Purchase Common Shares issued in exchange, transfer or replacement hereof, the “Warrant”) at any time and from time to time on or after the date hereof (the “Original Issue Date”), subject to the following terms and conditions:
1. Definitions. For purposes of this Warrant, the following terms shall have the following meanings:
(a) “Affiliate” means any Person directly or indirectly controlled by, controlling or under common control with, a Holder, as such terms are used in and construed under Rule 405 under the Securities Act, but only for so long as such control shall continue.
(b) “Closing Sale Price” means, for any security as of any date, the last trade price for such security on the Principal Trading Market for such security, as reported by Bloomberg L.P., or, if such Principal Trading Market begins to operate on an extended hours basis and does not designate the last trade price, then the last trade price of such security prior to 4:00 P.M., New York City time, as reported by Bloomberg L.P., or if the security is not listed for trading on the TSX Venture Exchange, a national securities exchange or other trading market on the relevant date, the last quoted bid price for the security in the over-the-counter market on the relevant date as reported by OTC Markets Group Inc. (or a similar organization or agency succeeding to its functions of reporting prices). If the Closing Sale Price cannot be calculated for a security on a particular date on any of the foregoing bases, the Closing Sale Price of such security on such date shall be the fair market value as mutually determined by the Company and the Holder. If the Company and the Holder are unable to agree upon the fair market value of such security, then the Board of Directors of the Company shall use its good faith judgment to determine the fair market value. The Board of Directors’ determination shall be binding upon all parties absent demonstrable error. All such determinations shall be appropriately adjusted for any share dividend, share split, share consolidation or other similar transaction during the applicable calculation period.
(c) “Commission” means the United States Securities and Exchange Commission.
(d) “Principal Trading Market” means the national securities exchange or other trading market on which the Common Shares is primarily listed and quoted for trading, which, as of the Original Issue Date, shall be deemed to be The Nasdaq Capital Market.
(e) “Registration Statement” means the Company’s Registration Statement on Form F-1, as amended (File No. 333-293217).
(f) “Securities Act” means the Securities Act of 1933, as amended.
(g) “Trading Day” means any weekday on which the Principal Trading Market is open for trading. If the Common Shares are not listed or admitted for trading, “Trading Day” means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day on which banking institutions in New York City are authorized or required by law or other governmental action to close.
(h) “Transfer Agent” means Computershare Investor Services Inc., the Company’s transfer agent and registrar for the Common Shares, and any successor appointed in such capacity.
2. Issuance of Securities; Registration of Warrants. The Warrant, as initially issued by the Company, is offered and sold pursuant to the Registration Statement. As of the Original Issue Date, the Warrant Shares are issuable under the Registration Statement. Accordingly, the Warrant and, assuming issuance pursuant to the Registration Statement or an exchange meeting the requirements of Section 3(a)(9) of the Securities Act, the Warrant Shares, are not “restricted securities” under Rule 144 promulgated under the Securities Act as of the Original Issue Date. The Company shall register ownership of this Warrant, upon records to be maintained by the Company for that purpose (the “Warrant Register”), in the name of the record Holder (which shall include the initial Holder or, as the case may be, any assignee to which this Warrant is permissibly assigned hereunder) from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.
3. Registration of Transfers. Subject to compliance with all applicable securities laws and the rules of the Principal Trading Market, the Company shall, or will cause its Transfer Agent to, register the transfer of all or any portion of this Warrant in the Warrant Register, upon surrender of this Warrant, and payment for all applicable transfer taxes (if any). Upon any such registration or transfer, a new warrant to purchase Common Shares in substantially the form of this Warrant (any such new warrant, a “New Warrant”) evidencing the portion of this Warrant so transferred shall be issued to the transferee, and a New Warrant evidencing the remaining portion of this Warrant not so transferred, if any, shall be issued to the transferring Holder. The acceptance of the New Warrant by the transferee thereof shall be deemed the acceptance by such transferee of all of the rights and obligations in respect of the New Warrant that the Holder has in respect of this Warrant. The Company shall, or will cause its Transfer Agent to, prepare, issue and deliver at the Company’s own expense any New Warrant under this Section 3. Until due presentment for registration of transfer, the Company may treat the registered Holder hereof as the owner and holder for all purposes, and the Company shall not be affected by any notice to the contrary.
4. Exercise and Duration of Warrants.
(a) All or any part of this Warrant shall be exercisable by the registered Holder in any manner permitted by this Warrant at any time and from time to time on or after the Original Issue Date.
(b) The Holder may exercise this Warrant by delivering to the Company (i) an exercise notice, in the form attached as Schedule 1 hereto (the “Exercise Notice”), completed and duly signed, and (ii) payment of the Exercise Price for the number of Warrant Shares as to which this Warrant is being exercised (which may take the form of a “cashless exercise” if so indicated in the Exercise Notice pursuant to Section 10 below). The date on which such exercise notice is delivered to the Company (as determined in accordance with the notice provisions hereof) is an “Exercise Date.” The Holder shall not be required to deliver the original Warrant in order to effect an exercise hereunder. Execution and delivery of the Exercise Notice shall have the same effect as cancellation of the original Warrant and issuance of a New Warrant evidencing the right to purchase the remaining number of Warrant Shares, if any. The aggregate exercise price of this Warrant, except for the Exercise Price, was pre-funded to the Company on or before the Original Issue Date, and consequently no additional consideration (other than the Exercise Price) shall be required to be paid by the Holder to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-funded exercise price under any circumstance or for any reason whatsoever. The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.
5. Delivery of Warrant Shares.
(a) Upon exercise of this Warrant, the Company shall promptly (but in no event later than one (1) Trading Day after the Exercise Date), upon the request of the Holder, cause the Transfer Agent to credit such aggregate number of Common Shares to which the Holder is entitled pursuant to such exercise to the Holder’s or its designee’s balance account with The Depository Trust Company (“DTC”) through its Deposit Withdrawal Agent Commission system, or if the Transfer Agent is not participating in the Fast Automated Securities Transfer Program (the “FAST Program”) or if the certificates or book entry position are required to bear a legend regarding restriction on transferability, issue and dispatch by overnight courier to the address as specified in the Exercise Notice, a certificate or book entry position, registered in the Company’s share register in the name of the Holder or its designee, for the number of Common Shares to which the Holder is entitled pursuant to such exercise. The Holder, or any natural person or legal entity (each, a “Person”) permissibly so designated by the Holder to receive Warrant Shares, shall be deemed to have become the holder of record of such Warrant Shares as of the Exercise Date, irrespective of the date such Warrant Shares are credited to the Holder’s DTC account or the date of delivery of the certificates or book entry position evidencing such Warrant Shares, as the case may be.
(b) If by the close of the first (1st) Trading Day after the Exercise Date, the Company fails to deliver to the Holder a certificate or book entry position representing the required number of Warrant Shares in the manner required pursuant to Section 5(a) or fails to cause the Transfer Agent to credit the Holder’s DTC account for such number of Warrant Shares to which the Holder is entitled, and if after such first (1st) Trading Day and prior to the receipt of such Warrant Shares, the Holder purchases (in an open market transaction or otherwise, provided such purchases shall be made in a commercially reasonable manner at prevailing market prices) Common Shares to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a “Buy-In”), then the Company shall, within three (3) Trading Days after the Holder’s written request (i) pay cash to the Holder in an amount equal to the excess (if any) of Holder’s total purchase price (including commercially reasonable brokerage commissions, if any) for the Common Shares so purchased in the Buy-In (assuming such sale was executed on commercially reasonable terms at prevailing market prices) over the product of (A) the number of Common Shares purchased in the Buy-In, times (B) the Closing Sale Price of a share of Common Shares on the Exercise Date and (ii) at the option of the Holder, either promptly deliver to the Holder a certificate or certificates representing such Warrant Shares or reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded).
(c) Subject to Section 5(b), nothing herein shall limit the Holder's right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company's failure to timely deliver certificates representing Common Shares upon exercise of the Warrant as required pursuant to the terms hereof.
6. Charges, Taxes and Expenses. Issuance and delivery of certificates for Common Shares, if any, upon exercise of this Warrant shall be made without charge to the Holder for any issue or transfer tax, transfer agent fee or other incidental tax or expense (excluding any applicable stamp duties) in respect of the issuance of such certificates, all of which taxes and expenses shall be paid by the Company; provided, however, that the Company shall not be required to pay any tax that may be payable in respect of any transfer involved in the registration of any certificates for Warrant Shares or the Warrants in a name other than that of the Holder or an Affiliate thereof. The Holder shall be responsible for all other tax liability that may arise as a result of holding or transferring this Warrant or receiving Warrant Shares upon exercise hereof.
7. Replacement of Warrant. If this Warrant is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation hereof, or in lieu of and substitution for this Warrant, a New Warrant, but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction (in such case) and, in each case, a customary and reasonable indemnity and surety bond, if requested by the Company. Applicants for a New Warrant under such circumstances shall also comply with such other reasonable regulations and procedures and pay such other reasonable third-party costs as the Company may prescribe. If a New Warrant is requested as a result of a mutilation of this Warrant, then the Holder shall deliver such mutilated Warrant to the Company as a condition precedent to the Company’s obligation to issue the New Warrant.
8. Reservation of Warrant Shares. The Company covenants that it will, at all times while this Warrant is outstanding, reserve and keep available out of the aggregate of its authorized but unissued and otherwise unreserved Common Shares, solely for the purpose of enabling it to issue Warrant Shares upon exercise of this Warrant as herein provided, the number of Warrant Shares that are initially issuable and deliverable upon the exercise of this entire Warrant, free from preemptive rights or any other contingent purchase rights of persons other than the Holder (taking into account the adjustments and restrictions of Section 9). The Company covenants that all Warrant Shares so issuable and deliverable shall, upon issuance and the payment of the applicable Exercise Price in accordance with the terms hereof, be duly and validly authorized, issued and fully paid and non-assessable. The Company will take all such action as may be reasonably necessary to assure that such Common Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of any securities exchange or automated quotation system upon which the Common Shares may be listed. The Company further covenants that it will not, without the prior written consent of the Holder, take any actions to reduce the number of authorized Common Shares at any time while this Warrant is outstanding if such reduction would cause the number of authorized Common Shares to be insufficient to permit the exercise of this Warrant in full.
9. Certain Adjustments. The Exercise Price and number of Warrant Shares issuable upon exercise of this Warrant are subject to adjustment from time to time as set forth in this Section 9.
(a) Share Dividends and Splits. If the Company, at any time while this Warrant is outstanding, (i) pays a share dividend on its Common Shares or otherwise makes a distribution on any class of its share capital issued and outstanding on the Original Issue Date and in accordance with the terms of such share on the Original Issue Date, as described in the Registration Statement, that is payable in Common Shares, (ii) subdivides its outstanding Common Shares into a larger number of Common Shares, (iii) combines or consolidates its outstanding Common Shares into a smaller number of Common Shares or (iv) issues by reclassification of its share capital any additional Common Shares of the Company, then in each such case the Exercise Price shall be multiplied by a fraction, the numerator of which shall be the number of Common Shares outstanding immediately before such event and the denominator of which shall be the number of Common Shares outstanding immediately after such event. Any adjustment made pursuant to clause (i) of this paragraph shall become effective immediately after the record date for the determination of shareholders entitled to receive such dividend or distribution, provided, however, that if such record date shall have been fixed and such dividend is not fully paid on the date fixed therefor, the Exercise Price shall be recomputed accordingly as of the close of business on such record date and thereafter the Exercise Price shall be adjusted pursuant to this paragraph as of the time of actual payment of such dividends. Any adjustment pursuant to clause (ii) or (iii) of this paragraph shall become effective immediately after the effective date of such subdivision or combination.
(b) Pro Rata Distributions. If the Company, at any time while this Warrant is outstanding, distributes to all holders of Common Shares for no consideration (i) evidences of its indebtedness, (ii) any security (other than a distribution of Common Shares covered by the preceding paragraph) (iii) rights or warrants to subscribe for or purchase any security, or (iv) cash or any other asset (in each case, a “Distribution”), other than a reclassification as to which Section 9(c) applies, then in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of Common Shares acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the ownership limitation set forth in Section 11(a) hereof) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of Common Shares are to be determined for the participation in such Distribution, provided, however, to the extent that the Holder’s right to participate in any such Distribution would result in the Holder exceeding the ownership limitation set forth in Section 11(a) hereof, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any Common Shares as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until the earlier of (i) such time, if ever, as the delivery to such Holder of such portion would not result in the Holder exceeding the ownership limitation set forth in Section 11(a) hereof and (ii) such time as the Holder has exercised this Warrant.
(c) Fundamental Transactions. If, at any time while this Warrant is outstanding (i) the Company effects any merger or consolidation of the Company with or into another Person, in which the Company is not the surviving entity and in which the shareholders of the Company immediately prior to such merger or consolidation do not own, directly or indirectly, at least 50% of the voting power of the surviving entity immediately after such merger or consolidation, (ii) the Company effects any sale, transfer or disposition to another Person of all or substantially all of its assets in one transaction or a series of related transactions (which, for the avoidance of doubt, shall exclude any such transactions undertaken by and amongst the Company and its subsidiaries for the purposes of a reorganization, recapitalization or similar plan of arrangement), (iii) pursuant to any tender offer or exchange offer (whether by the Company or another Person), holders of share capital tender shares representing more than 50% of the voting power of the Company’s share capital and the Company or such other Person, as applicable, accepts such tender for payment, (iv) the Company consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or plan of arrangement) with another Person whereby such other Person acquires more than the 50% of the voting power of the share capital of the Company (except for any such transaction in which the shareholders of the Company immediately prior to such transaction maintain, in substantially the same proportions, the voting power of such Person immediately after the transaction) or (v) the Company effects any reclassification of the Common Shares or any compulsory share exchange pursuant to which the Common Shares are effectively converted into or exchanged for other securities, cash or property (other than as a result of a subdivision or combination of Common Shares covered by Section 9(a) above) (in any such case, a “Fundamental Transaction”), then following such Fundamental Transaction the Holder shall have the right to receive, upon exercise of this Warrant, the same amount and kind of securities, cash or property as it would have been entitled to receive upon the occurrence of such Fundamental Transaction if it had been, immediately prior to such Fundamental Transaction, the holder of the number of Warrant Shares then issuable upon exercise in full of this Warrant without regard to any limitations on exercise contained herein (the “Alternate Consideration”). The Company shall not effect any Fundamental Transaction in which the Company is not the surviving entity or the Alternate Consideration includes securities of another Person unless (i) the Alternate Consideration is solely cash and the Company provides for the simultaneous “cashless exercise” of this Warrant pursuant to Section 10 below or (ii) prior to or simultaneously with the consummation thereof, any successor to the Company, surviving entity or other Person (including any purchaser of assets of the Company) shall assume the obligation to deliver to the Holder such Alternate Consideration as, in accordance with the foregoing provisions, the Holder may be entitled to receive, and the other obligations under this Warrant. For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one Common Share in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. The provisions of this paragraph (c) shall similarly apply to subsequent transactions analogous of a Fundamental Transaction type.
(d) Number of Warrant Shares. Simultaneously with any adjustment to the Exercise Price pursuant to Section 9 (including any adjustment to the Exercise Price that would have been effected but for the final sentence in this paragraph (d)), the number of Warrant Shares that may be purchased upon exercise of this Warrant shall be increased or decreased proportionately, so that after such adjustment the aggregate Exercise Price payable hereunder for the increased or decreased number of Warrant Shares shall be the same as the aggregate Exercise Price in effect immediately prior to such adjustment.
(e) Calculations. All calculations under this Section 9 shall be made to the nearest one-hundredth of one cent or the nearest 1/100th of a share, as applicable.
(f) Notice of Adjustments. Upon the occurrence of each adjustment pursuant to this Section 9, the Company at its expense will, at the written request of the Holder, promptly compute such adjustment, in good faith, in accordance with the terms of this Warrant and prepare a certificate setting forth such adjustment, including a statement of the adjusted Exercise Price and adjusted number or type of Warrant Shares or other securities issuable upon exercise of this Warrant (as applicable), describing the transactions giving rise to such adjustments and showing in detail the facts upon which such adjustment is based. Upon written request, the Company will promptly deliver a copy of each such certificate to the Holder and to the warrant agent, if applicable.
(g) Notice of Corporate Events. If, while this Warrant is outstanding, the Company (i) declares a dividend or any other distribution of cash, securities or other property in respect of its Common Shares, including, without limitation, any granting of rights or warrants to subscribe for or purchase any share capital of the Company or any subsidiary, (ii) authorizes or approves, enters into any agreement contemplating or solicits shareholder approval for any Fundamental Transaction or (iii) authorizes the voluntary dissolution, liquidation or winding up of the affairs of the Company, then, except if such notice and the contents thereof shall be deemed to constitute material non-public information, the Company shall deliver to the Holder a notice of such transaction at least ten (10) days prior to the applicable record or effective date on which a Person would need to hold Common Shares in order to participate in or vote with respect to such transaction; provided, however, that the failure to deliver such notice or any defect therein shall not affect the validity of the corporate action required to be described in such notice. In addition, if while this Warrant is outstanding, the Company authorizes or approves, enters into any agreement contemplating or solicits shareholder approval for any Fundamental Transaction contemplated by Section 9(c), other than a Fundamental Transaction under clause (iii) of Section 9(c), then, except if such notice and the contents thereof shall be deemed to constitute material non-public information, the Company shall deliver to the Holder a notice of such Fundamental Transaction at least ten (10) days prior to the date such Fundamental Transaction is consummated.
10. Payment of Cashless Exercise Price. Notwithstanding anything contained herein to the contrary, the Holder may, in its sole discretion, satisfy its obligation to pay the Exercise Price through a “cashless exercise,” in which event the Company shall issue to the Holder the number of Warrant Shares in an exchange of securities effected pursuant to Section 3(a)(9) of the Securities Act as determined as follows:
X = Y [(A-B)/A]
where:
“X” equals the number of Warrant Shares to be issued to the Holder;
“Y” equals the total number of Warrant Shares with respect to which this Warrant is then being exercised;
“A” equals the Closing Sale Price per share of Common Shares as of the Trading Day on the date immediately preceding the Exercise Date; and
“B” equals the Exercise Price per Warrant Share then in effect on the Exercise Date.
For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in such a “cashless exercise” transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the Original Issue Date (provided that the Commission continues to take the position that such treatment is proper at the time of such exercise). In the event that the Registration Statement or another registration statement registering the issuance of Warrant Shares is, for any reason, not effective at the time of exercise of this Warrant, then this Warrant may only be exercised through a cashless exercise, as set forth in this Section 10.
Except as otherwise set forth herein, in no event will the exercise of this Warrant be settled in cash.
11. Limitations on Exercise.
(a) Notwithstanding anything to the contrary contained herein, the Company shall not effect any exercise of this Warrant, and the Holder shall not be entitled to exercise this Warrant for a number of Warrant Shares in excess of that number of Warrant Shares which, upon giving effect to such exercise, would cause the aggregate number of Common Shares beneficially owned by the Holder, its Affiliates and any other Persons whose beneficial ownership of Common Shares would be aggregated with the Holder’s for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), to exceed 9.99% (the “Maximum Percentage”) of the total number of issued and outstanding Common Shares of the Company following such exercise. To the extent that the Maximum Percentage applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of an Exercise Notice shall be deemed to be the Holder’s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates) and of which portion of this Warrant is exercisable, in each case subject to the Maximum Percentage, and the Company shall have no obligation to verify or confirm the accuracy of such determination. For purposes of this Warrant, in determining the number of outstanding Common Shares, the Holder may rely on the number of outstanding Common Shares as reflected in (x) the Company’s most recent Form 10-Q or Form 10-K, as the case may be, filed with the Commission prior to the Exercise Date, (y) a more recent public announcement by the Company or (z) any other notice by the Company or the Transfer Agent setting forth the number of Common Shares outstanding. Upon the written request of the Holder, the Company shall within three (3) Trading Days confirm in writing or by electronic mail to the Holder the number of Common Shares then outstanding. In any case, the number of outstanding Common Shares shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder since the date as of which such number of outstanding Common Shares was reported. By written notice to the Company, the Holder may from time to time increase or decrease the Maximum Percentage to any other percentage not in excess of 9.99% specified in such notice; provided that any such increase or decrease will not be effective until the sixty-first (61st) day after such notice is delivered to the Company. For purposes of this Section 11(a), the aggregate number of Common Shares beneficially owned by the Holder and its Affiliates and any other Persons whose beneficial ownership of Common Shares would be aggregated with the Holder’s for purposes of Section 13(d) of the Exchange Act shall include the Common Shares issuable upon the exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of Common Shares which would be issuable upon (x) exercise of the remaining unexercised and non-cancelled portion of this Warrant by the Holder and (y) exercise or conversion of the unexercised, non-converted or non-cancelled portion of any other securities of the Company that do not have voting power (including without limitation any securities of the Company which would entitle the holder thereof to acquire at any time Common Shares, including without limitation any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Shares), is subject to a limitation on conversion or exercise analogous to the limitation contained herein and is beneficially owned by the Holder or any of its Affiliates and other Persons whose beneficial ownership of Common Shares would be aggregated with the Holder’s for purposes of Section 13(d) of the Exchange Act.
(b) This Section 11 shall not restrict the number of Common Shares which a Holder may receive or beneficially own in order to determine the amount of securities or other consideration that such Holder may receive in the event of a Fundamental Transaction as contemplated in Section 9(c) of this Warrant.
12. No Fractional Shares. No fractional Warrant Shares will be issued in connection with any exercise of this Warrant. In lieu of any fractional shares that would otherwise be issuable, the number of Warrant Shares to be issued shall be rounded down to the next whole number and the Company shall pay the Holder in cash the fair market value (based on the Closing Sale Price) for any such fractional shares.
13. Notices. Any and all notices or other communications or deliveries hereunder (including, without limitation, any Exercise Notice) shall be in writing and shall be deemed given and effective on the earliest of (i) the date of transmission, if such notice or communication is delivered via facsimile or confirmed e-mail prior to 5:30 P.M., New York City time, on a Trading Day, (ii) the next Trading Day after the date of transmission, if such notice or communication is delivered via facsimile or confirmed e-mail on a day that is not a Trading Day or later than 5:30 P.M., New York City time, on any Trading Day, (iii) the Trading Day following the date of mailing, if sent by nationally recognized overnight courier service specifying next business day delivery, or (iv) upon actual receipt by the Person to whom such notice is required to be given, if by hand delivery. The addresses, telephone numbers and e-mail addresses for such communications shall be:
If to the Company:
187 Ballardvale Street, Suite 110
Wilmington, Massachusetts 01887
Telephone number: 888-617-7226
Attention: William Frain
Email: bfrain@libertydefense.com
If to the Holder, to its address, facsimile number or e-mail address set forth herein or on the books and records of the Company.
Or, in each of the above instances, to such other address, facsimile number or e-mail address as the recipient party has specified by written notice given to each other party at least five (5) days prior to the effectiveness of such change.
14. Warrant Agent. The Company shall initially serve as warrant agent under this Warrant. Upon ten (10) days’ notice to the Holder, the Company may appoint a new warrant agent. Any corporation into which the Company or any new warrant agent may be merged or any corporation resulting from any consolidation to which the Company or any new warrant agent shall be a party or any corporation to which the Company or any new warrant agent transfers substantially all of its corporate trust or shareholders services business shall be a successor warrant agent under this Warrant without any further act. Any such successor warrant agent shall promptly cause notice of its succession as warrant agent to be mailed (by first class mail, postage prepaid) to the Holder at the Holder’s last address as shown on the Warrant Register.
15. Miscellaneous.
(a) No Rights as a Shareholder. The Holder, solely in such Person’s capacity as a holder of this Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of share capital of the Company for any purpose, nor shall anything contained in this Warrant be construed to confer upon the Holder, solely in such Person’s capacity as the Holder of this Warrant, any of the rights of a shareholder of the Company or any right to vote, give or withhold consent to any corporate action (whether any reorganization, issue of shares, reclassification of shares, consolidation, merger, amalgamation, conveyance or otherwise), receive notice of meetings, receive dividends or subscription rights, or otherwise, prior to the issuance to the Holder of the Warrant Shares which such Person is then entitled to receive upon the due exercise of this Warrant. In addition, nothing contained in this Warrant shall be construed as imposing any liabilities on the Holder to purchase any securities (upon exercise of this Warrant or otherwise) or as a shareholder of the Company, whether such liabilities are asserted by the Company or by creditors of the Company.
(b) Authorized Shares. Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its notice of articles or articles or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company will (a) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and non-assessable Warrant Shares upon the exercise of this Warrant, and (b) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof as may be necessary to enable the Company to perform its obligations under this Warrant.
(c) Successors and Assigns. Subject to compliance with applicable securities laws, this Warrant may be assigned by the Holder. This Warrant may not be assigned by the Company without the written consent of the Holder, except to a successor in the event of a Fundamental Transaction. This Warrant shall be binding on and inure to the benefit of the Company and the Holder and their respective successors and assigns. Subject to the preceding sentence, nothing in this Warrant shall be construed to give to any Person other than the Company and the Holder any legal or equitable right, remedy or cause of action under this Warrant. This Warrant may be amended only in writing signed by the Company and the Holder, or their successors and assigns.
(d) Amendment and Waiver. Except as otherwise provided herein, the provisions of the Warrants may be amended and the Company may take any action herein prohibited, or omit to perform any act herein required to be performed by it, only if the Company has obtained the written consent of the Holder.
(e) Acceptance. Receipt of this Warrant by the Holder shall constitute acceptance of and agreement to all of the terms and conditions contained herein.
(f) Governing Law; Jurisdiction. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law. Without limiting any other provision of this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys' fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder. Each of the Company and the Holder hereby waives all rights to a trial by jury. Notwithstanding the foregoing, the provisions of this paragraph will not apply to any actions arising under the Securities Act or Exchange Act.
(g) Headings. The headings herein are for convenience only, do not constitute a part of this Warrant and shall not be deemed to limit or affect any of the provisions hereof.
(h) Severability. In case any one or more of the provisions of this Warrant shall be invalid or unenforceable in any respect, the validity and enforceability of the remaining terms and provisions of this Warrant shall not in any way be affected or impaired thereby, and the Company and the Holder will attempt in good faith to agree upon a valid and enforceable provision which shall be a commercially reasonable substitute therefor, and upon so agreeing, shall incorporate such substitute provision in this Warrant.
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]
IN WITNESS WHEREOF, the Company has caused this Warrant to be duly executed by its authorized officer as of the date first indicated above.
| LIBERTY DEFENSE HOLDINGS, LTD. | ||
| By: | ||
| Name: William Frain | ||
| Title: Chief Executive Officer | ||
[Signature Page to Pre-Funded Warrant]
SCHEDULE 1
FORM OF EXERCISE NOTICE
[To be executed by the Holder to purchase Warrant Shares under the Warrant]
Ladies and Gentlemen:
(1) The undersigned is the Holder of Warrant No. ___ (the “Warrant”) issued by Liberty Defense Holdings, Ltd., a corporation incorporated under the laws of the Province of British Columbia (the “Company”). Capitalized terms used herein and not otherwise defined herein have the respective meanings set forth in the Warrant.
(2) The undersigned hereby exercises its right to purchase Warrant Shares pursuant to the Warrant.
(3) The Holder intends that payment of the Exercise Price shall be made as (check one):
| ¨ | Cash Exercise |
| ¨ | “Cashless Exercise” under Section 10 of the Warrant |
(4) If the Holder has elected a Cash Exercise, the Holder shall pay the sum of $ __________ in immediately available funds to the Company in accordance with the terms of the Warrant.
(5) Pursuant to this Exercise Notice, the Company shall deliver to the Holder Warrant Shares determined in accordance with the terms of the Warrant. The Warrant Shares shall be delivered to the following DWAC Account Number:
(6) By its delivery of this Exercise Notice, the undersigned represents and warrants to the Company that in giving effect to the exercise evidenced hereby the Holder, its Affiliates and any other Person whose beneficial ownership of Common Shares would be aggregated with the Holder’s for purposes of Section 13(d) of the Exchange Act will not beneficially own in excess of the number of Common Shares (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended) permitted to be owned under Section 11(a) of the Warrant to which this notice relates.
| Dated: | ||
| Name of Holder: | ||
| By: | ||
| Name: | ||
| Title: |
(Signature must conform in all respects to name of Holder as specified on the face of the Warrant)
Exhibit 5.2

March 30, 2026
Liberty Defense Holdings, Ltd.
187 Ballardvale Street, Suite 110
Wilmington, Massachusetts 01887
Liberty Defense Holdings, Ltd.
Registration Statement on Form F-1
Ladies and Gentlemen:
We have acted as special U.S. counsel to Liberty Defense Holdings, Ltd., a British Columbia corporation (the “Company”), in connection with the Registration Statement on Form F-1 (File No. 333-293217) initially filed by the Company on February 5, 2026 (as amended and supplemented from time to time, the “Registration Statement”) with the Securities and Exchange Commission (the “SEC”) in connection with the registration under the Securities Act of 1933, as amended (the “Securities Act”), of (i) a number of the Company’s common shares, no par value (“Common Shares”), (ii) a number of pre-funded warrants to purchase Common Shares (the “Pre-Funded Warrants”), pursuant to the underwriting agreement (the “Underwriting Agreement”) to be entered into between the Company and The Benchmark Company, LLC (the “Underwriter”), and (iii) a number of Common Shares issuable upon the exercise of the Pre-Funded Warrants, each in amounts specified in the Registration Statement and to be sold or issued, as applicable, by the Company. This opinion letter is being furnished in accordance with the requirements of Item 8(a) of Form F-1 and Item 601(b)(5)(i) of Regulation S-K under the Securities Act.
Documents Reviewed
In connection with this opinion letter, we have examined the following documents:
(a) the Registration Statement;
(b) the prospectus contained in the Registration Statement (the “Prospectus”);
(c) the form of Underwriting Agreement, filed as Exhibit 1.1 to the Registration Statement; and
(d) the form of Pre-Funded Warrant, filed as Exhibit 4.1 to the Registration Statement.
In addition, we have examined and relied upon originals, or copies identified to our satisfaction as being true copies, of such other records, documents and instruments as we have deemed necessary for the purposes of this opinion letter.
Assumptions Underlying Our Opinion
For all purposes of the opinion expressed herein, we have assumed, without independent investigation, the following:
(a) Factual Matters. To the extent that we have reviewed and relied upon (i) certificates of the Company or authorized representatives thereof, (ii) representations of the Company as set forth in the Underwriting Agreement and (iii) certificates and assurances from public officials, all of such certificates, representations and assurances are accurate with regard to factual matters and all official records (including filings with public authorities) are properly indexed and filed and are accurate and complete.
(b) Authentic and Conforming Documents. All documents submitted to us as originals are authentic, complete and accurate, and all documents submitted to us as copies conform to authentic original documents.
(c) Signatures; Legal Capacity. The signatures of individuals who have signed or will sign the Underwriting Agreement and the Pre-Funded Warrants are genuine. All individuals who will sign the Underwriting Agreement and the Pre-Funded Warrants have the legal capacity to execute the Underwriting Agreement and the Pre-Funded Warrants.
(d) Organizational Status, Power and Authority of Certain Parties. All parties to the Underwriting Agreement and the Pre-Funded Warrants (other than any individual) (i) are or will be, as of the date the Underwriting Agreement and the Pre-Funded Warrants are executed and delivered, validly existing and in good standing in their respective jurisdictions of formation and (ii) have or will have, as of the date the Underwriting Agreement and the Pre-Funded Warrants are executed and delivered, the capacity and full power and authority to execute, deliver and perform the Underwriting Agreement and the Pre-Funded Warrants and the documents required or permitted to be delivered and performed thereunder.
(e) Authorization, Execution and Delivery. The Underwriting Agreement and the Pre-Funded Warrants and the documents required or permitted to be delivered thereunder will have been duly authorized by all necessary corporate, limited liability company, business trust, partnership or other action on the part of the parties thereto and have been or will be, as of the date the Underwriting Agreement and the Pre-Funded Warrants are executed and delivered, duly executed and delivered by such parties.
(f) Subject Documents Binding on Certain Parties. The Underwriting Agreement and the documents required or permitted to be delivered thereunder are or will be, as of the date the Underwriting Agreement is executed and delivered, valid and binding obligations enforceable against the parties thereto in accordance with their terms.
(g) Form of Certain Documents. The Underwriting Agreement and the Pre-Funded Warrants, the forms of which are filed as exhibits to the Registration Statement, will be consistent with such respective forms.
(h) Noncontravention. Neither the issuance of the Pre-Funded Warrants by the Company or the execution and delivery of the Underwriting Agreement or the Pre-Funded Warrants by any party thereto nor the performance by such party of its obligations thereunder will conflict with or result in a breach of (i) the certificate or articles of incorporation, bylaws, certificate or articles of organization, operating agreement, certificate of limited partnership, partnership agreement, trust agreement or other similar organizational documents of any such party, (ii) any law or regulation of any jurisdiction applicable to any such party, except that no such assumption is made as to the Company as to any Applicable Law (as defined below) as of the date hereof, or (iii) any order, writ, injunction or decree of any court or governmental instrumentality or agency applicable to any such party or any agreement or instrument to which any such party may be a party or by which its properties are subject or bound.
2
(i) Registration. The Registration Statement shall have been declared effective under the Securities Act and such effectiveness shall not have been terminated or rescinded.
(j) No Mutual Mistake, Amendments, etc. There has not been, and will not be, as of the date of the Underwriting Agreement, any mutual mistake of fact, fraud, duress or undue influence in connection with the issuance of the Pre-Funded Warrants as contemplated by the Registration Statement, Prospectus and the Underwriting Agreement. There are and will be no oral or written statements or agreements that modify, amend or vary, or purport to modify, amend or vary, any of the terms of the Underwriting Agreement or the Pre-Funded Warrants.
Our Opinion
Based on and subject to the foregoing and the exclusions, qualifications, limitations and other assumptions set forth in this opinion letter, we are of the opinion that when the Pre-Funded Warrants have been executed and delivered by the Company and paid for by the purchasers thereof as contemplated by the Registration Statement, the Prospectus and the Underwriting Agreement, the Pre-Funded Warrants will constitute valid and binding obligations of the Company, enforceable against the Company in accordance with their terms.
Matters Excluded from Our Opinion
We express no opinion with respect to the following matter:
(a) Indemnification and Change of Control. The enforceability of any agreement relating to (i) indemnification, contribution or exculpation from costs, expenses or other liabilities or (ii) changes in the organizational control or ownership of any party, which agreement (in the case of clause (i) or clause (ii)) is contrary to public policy or Applicable Law.
(b) Jurisdiction, Venue, etc. The enforceability of any agreement to submit to the jurisdiction of any specific federal or state court (other than the enforceability in a court of the State of New York of any such agreement to submit to the jurisdiction of a court of the State of New York), to waive any objection to the laying of the venue, to waive the defense of forum non conveniens in any action or proceeding referred to therein, to waive trial by jury, to effect service of process in any particular manner or to establish evidentiary standards, and any agreement regarding the choice of law governing the Underwriting Agreement (other than the enforceability in a court of the State of New York or in a federal court sitting in New York and applying New York law to any such agreement that the laws of New York shall govern the Underwriting Agreement).
(c) Exercise Price Adjustments. The validity, legally binding effect or enforceability of any provision in the Pre-Funded Warrants that requires or relates to adjustments to the exercise price at a rate or in an amount that a court would determine in the circumstances under Applicable Law to be commercially unreasonable or a penalty or forfeiture.
Qualifications and Limitations Applicable to Our Opinion
The opinion set forth above is subject to the following qualifications and limitations.
(a) Applicable Law. Our opinion is limited to the federal laws of the United States and the internal laws of the State of New York (collectively, the “Applicable Law”), and we do not express any opinion concerning any other law.
3
(b) Bankruptcy. Our opinion is subject to the effect of any applicable bankruptcy, insolvency (including, without limitation, laws relating to preferences, fraudulent transfers and equitable subordination), reorganization, moratorium and other similar laws affecting creditors’ rights generally.
(c) Equitable Principles. Our opinion is subject to the effect of general principles of equity (regardless of whether considered in a proceeding in equity or at law), including, without limitation, concepts of materiality, reasonableness, good faith and fair dealing. In applying such principles, a court, among other things, might limit the availability of specific equitable remedies (such as injunctive relief and the remedy of specific performance), might not allow a creditor to accelerate maturity of debt or exercise other remedies upon the occurrence of a default deemed immaterial or for non-credit reasons or might decline to order a debtor to perform covenants in the Underwriting Agreement or the Pre-Funded Warrants.
(d) Unenforceability of Certain Provisions. Provisions contained in the Underwriting Agreement or the Pre-Funded Warrants which require waivers or amendments to be made only in writing may be unenforceable or ineffective, in whole or in part. The inclusion of such provisions, however, does not render the Underwriting Agreement or any of the Pre-Funded Warrants invalid as a whole.
(e) Choice of New York Law and Forum. To the extent that our opinion relates to the enforceability of the choice of New York law or any choice of New York forum provisions of the Pre-Funded Warrants, our opinion is rendered in reliance upon N.Y. Gen. Oblig. Law §§ 5-1401 and 5-1402 and N.Y. CPLR 327(b) and is subject to the qualification that such enforceability may be limited by principles of public policy, comity and constitutionality. We express no opinion as to whether a United States federal court would have subject-matter or personal jurisdiction over a controversy arising under the Underwriting Agreement or the Pre-Funded Warrants.
Miscellaneous
The foregoing opinion is being furnished only for the purpose referred to in the first paragraph of this opinion letter. Our opinion is based on statutes, regulations and administrative and judicial interpretations which are subject to change. We undertake no responsibility to update or supplement the opinion subsequent to the effective date of the Registration Statement. Headings in this opinion letter are intended for convenience of reference only and shall not affect its interpretation. We hereby consent to the filing of this opinion letter as Exhibit 5.2 to the Registration Statement, to the incorporation by reference of this letter into any subsequent registration statement on Form F-1 filed by the Company pursuant to Rule 462(b) of the Securities Act, and to the reference to our firm in the Registration Statement and the Prospectus under the caption “Legal Matters.” In giving this consent, we do not admit that we are within the category of persons whose consent is required by Section 7 of the Securities Act or the rules and regulations of the SEC promulgated thereunder.
| Very truly yours, | |
| /s/ McGuireWoods LLP |
4
Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the inclusion in this Registration Statement on Form F-1 of our report dated June 17, 2025, except for Note 19 and Note 23, as to which the date is March 19, 2026, relating to the consolidated financial statements of Liberty Defense Holdings Ltd. for the years ended December 31, 2024 and 2023, which are part of this Registration Statement
We also consent to the reference to us under the caption “Experts” in this Registration Statement.
/s/ Davidson & Company LLP
| Chartered Professional Accountants | Vancouver, Canada |
March 30, 2026
| DAVIDSON & COMPANY LLP | 1200 – 609 Granville Street PO BOX 10372, Pacific Centre Vancouver, BC V7Y 1G6 |
604 687 0947 davidson-co.com |